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Abstract  
Objective:   A diagnosis of cancer increasingly means living with a chronic disease 
whereby life is preserved but the individual has adverse experiences to manage in relation 
to treatment and illness symptoms.  Accordingly, research has focused on factors 
associated with psychological adjustment, one example being that of the expression of 
emotions.  The purpose of this review was to summarise findings on the association 
between emotional expression and psychological adjustment in patients with a diagnosis of 
cancer.  Specific questions are outlined in relation to the concepts of emotional expression 
used by researchers, the expression of separate emotions and the methods used to measure 
this construct.   
Methods: Following searches of electronic databases and key journals, 15 papers reporting 
on the outcomes of 13 individual studies met inclusion criteria.  Assessment of 
methodological quality was applied using a specifically designed rating tool. 
 Results: Findings from the majority of studies indicate that attempts to suppress, inhibit or 
control emotional expression is linked to poorer psychological adjustment and the 
expression of emotions is associated with better adjustment.  Several studies found 
suppression of certain emotions but not others were linked with psychological adjustment, 
however specific relationships were not consistent across studies.  Only two studies used 
methodologies other than self-report to measure emotional expression and there were some 
discrepancies in findings between these two approaches in relation to their association with 
both each other and psychological adjustment.        
Discussion: Main findings are outlined.  Methodological strengths and limitations are 
discussed with recommendations for future research and clinical practice implications.   
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Introduction 
Psychological adjustment in cancer patients 
Previously, until the 1950s, a diagnosis of cancer meant an expectation of death for the 
patient.  With the beginning of chemotherapy and improvements in life-sustaining supports 
at this time, came the first studies on psychological reactions to cancer [1].  From the 
1960s onwards there was an emphasis on palliative care and an increase in concern from 
the field of psychology about care for the terminally ill [1].   As technology further 
advances, an increasing number of people are living with what is now a chronic illness, 
whereby life is preserved but the individual has various adverse experiences to deal with in 
relation to treatment and illness symptoms.  As such, with what have recently been termed 
“survivorship initiatives”, there has been a move towards a focus on improving ongoing 
care for those living with and beyond cancer, in addition to high quality end of life care 
[2].  Accordingly, professionals caring for people with cancer and researchers in the field 
of “psycho-oncology” have turned their focus to patients‟ psychological adjustment to 
cancer [3].  Prevalence rates vary according to assessments used but an early 
comprehensive study by Derogatis and colleagues found that 47% of new admissions to 
three collaborating cancer centres met criteria for a formal diagnostic psychiatric disorder 
[4].  More recent reports suggest that around 35% of patients with cancer experience a 
level of distress consistent with a psychiatric disorder [5], with 15-20% experiencing levels 
that are sub-clinical but significant enough to impact on the individual‟s health and quality 
of life [6].  Not all cancer patients, however, experience significant distress, leading to 
investigation into factors impacting on psychological adjustment.  Studies have focused on 
both psychological and social factors in addition to demographic and medical/disease 
related factors, with some implicating a more prominent role of psychological factors in 
adjustment [7-10].   
 
Emotional Expression and non-expression in breast cancer populations 
One psychological construct that has received attention in research relating to both cancer 
and other chronic illness populations is emotional expression.  Several studies have pointed 
to higher levels of emotional suppression in patients with cancer [11-13], with some 
researchers proposing that it has a role in influencing the onset and progression of cancer 
and survival outcomes [14,15,16].  However, a more recent study by Graves and 
colleagues between cancer “survivors” and healthy controls found no difference on 
measures of emotional expression [17].  Similarly, Servae et al found no differences in 
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levels of emotional expression per se but that those with breast cancer reported more 
ambivalence towards emotional expression compared with controls [18].  It would seem 
that the association between the cancer experience and emotional expression remains 
equivocal and Graves et al suggest that this is likely to be due to methodological, statistical 
and conceptual differences between studies.  Nevertheless, on the premise that there may 
be some association between breast cancer and emotional expression, within the evolving 
research into psychological factors and psychological adjustment, several researchers have 
investigated whether this is one such associated variable.  Indeed, with the belief that 
emotional expression is “good” for psychological adjustment, intervention studies utilising 
it as a component have also been developed with some, but not consistently, reported 
improved outcomes [19,20].  
 
Constructs of emotional expression and non-expression 
Studies investigating the general concept of emotional expression and its associations with 
psychological adjustment in patients with cancer have utilised a number of overlapping but 
distinct psychological constructs.  In reviewing the literature in this area, it is important to 
consider first the constructs they are reporting to measure.   
One conceptualisation of emotional non-expression has been referred to as “emotional 
suppression”.  This term has been described as involving a conscious effort to inhibit 
expressive elements of emotional experiences [21].  An example of this might be 
somebody remaining outwardly calm while being churned up with anger inside.
I
  This 
latter description has also been referred to as “emotional inhibition”.   A related concept 
has been that of “emotional control”, likewise referring to a tendency for individuals to 
control the expression of emotions [23].  The use of these three terms in the literature 
appears to be interchangeable with studies purporting to be investigating emotional 
suppression or emotional inhibition using measures designed to measure emotional control.  
A more distinct form of non-expression, termed Alexithymia, refers to a deficit in 
expressing emotions and identifying feelings in the self and others [24].  While some 
researchers have focused on the non-expression of emotions, others have taken an 
“expression approach”, focusing on measuring the active expression of emotions.  
Although often not referred to by investigators in the area, a distinction should be 
acknowledged between emotional expression defined as spontaneous venting of negative 
                                                 
I
 Emotional suppression here, and throughout the text, refers to the suppression of emotional expression as 
opposed to the suppression of the experience of an emotion as the term has been used elsewhere [22].  
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emotions and as a cognitive process involving verbalisation and communication of inner 
emotional states [25].    
Considering the expression of separate emotions 
Investigators often refer to a general tendency towards emotional expression or its 
suppression, this being particularly evident in research on interventions incorporating 
emotional expression.  However, as is highlighted by Schlatter et al, different emotions 
may be linked with distinctive motivational, psychophysiological and behavioural 
processes and it is likely that their suppression will have different influences on 
psychological adjustment [21].  As such a number of studies have investigated the 
expression of different emotions in addition to the general expression of emotion.  
  
The present review 
In 2002 Panagopoulou et al conducted a meta-analysis reviewing the effects of emotional 
expression in chronic diseases [25]. The report aimed to identify the differential effect of 
emotional expression and non-expression on the course and adaptation to chronic disease.  
A weak but significant association was found between increases in psychological distress 
and emotional non-expression, but the inverse relation was not present for emotional 
expression.  The authors highlighted that future research should focus on longitudinal 
designs exploring effects of emotional expression on the psychological adaptation to 
chronic disease and that the implications of emotional expression in the course of various 
forms of medical treatment should be explored. A limit to this review was that it did not 
delineate potential differences in the relation of the expression of separate emotions and 
their association with psychological adjustment. 
A number of studies have been conducted since Panagopoulou‟s report, with a proportion 
incorporating a longitudinal element to their design.  Further, while research has 
traditionally used self-report as a measurement of emotional expression, with the 
acknowledgement of potential limits to this, use of other attempts to measure this construct 
has emerged.  It was therefore considered timely to review the literature in this area as it 
stands, with a focus on cancer populations.  
Aims 
 
The present review aims to establish findings on the association between emotional 
expression/non-expression and psychological adjustment in patients with a diagnosis of 
cancer by summarising and evaluating relevant studies in this area.  The review 
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incorporates research from both the non-expression and expression approach, 
acknowledging the conceptual differences between the two.  For conciseness, however, the 
term emotional expression will be used to incorporate the two distinct approaches 
simultaneously other than where the distinction is required for comparison purposes.  In 
light of the literature and conceptual considerations outlined above, an initial general 
question emerges followed by three specific questions:     
 
Research Questions  
1) What is the evidence for an association between emotional expression and 
psychological adjustment in people with cancer?  
2) Are there differential relationships between the different concepts of emotional 
expression and their association with psychological adjustment?  
3) Is the expression of different emotions differentially associated with psychological 
adjustment? 
4) How do the results of studies using self-report measures of emotional expression 
compare to those utilising other approaches to its measurement?    
 
Methods 
 
Search strategy 
To identify potentially suitable studies the following electronic databases were searched 
from start of indexing to June 2011:  Ovid Medline, Embase, Psychinfo and All EBM 
Reviews.  Limits were set on search terms to include „English language‟, „human‟ and 
„adults >18years‟.   
The search terms used were:  
1. [cancer*] OR [neoplasm*] OR [tumo?r] or [carcinogen*] 
2. emotion* adj2 [inhibit* or  suppress* or express* or control* or repress* or 
regulat*] OR [alexithymia] 
3. [distress*] OR [stress] OR [mood] OR [depress*] or [anxiety*] OR [wellbeing] OR 
[mental health] OR [adjustment] OR psychological adj2 [response* or symptom* 
or morbid* or outcome*]  
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The results of these searches were then combined using the Boolean operator „AND‟.  
Search terms were also mapped onto relevant subject headings.   
 
Inclusion/exclusion criteria 
Cancer populations do not necessarily represent a homogenous group with the experience 
of each type of cancer bringing its unique set of stressors, however it was deemed that 
there are certain common experiences across cancer groups allowing for consideration of 
the population as a whole.  Further, there is evidence to suggest that levels of 
psychological distress do not necessarily differ according to cancer type [26].  The primary 
focus of this review was to question the association between measures of emotional 
expression and psychological adjustment to cancer.  There were a number of studies that 
explored relationships between these two variables to some degree, but that did not quite 
report on this specifically.  For example, studies evaluating psychological interventions 
which include emotional expression as a treatment component were excluded because it is 
not possible to separate out the specific effects of emotional expression from other aspects 
of treatment.  Those studies investigating emotional expression as a moderating or 
mediating variable of the association between two other variables were also excluded on 
the basis that inclusion of these studies would arguably result in the scope of the review 
becoming too broad, with difficulties arising in the cross-comparison of findings.  In 
operationalising psychological adjustment, studies were included if they included indices 
of positive adjustment such as positive affect and well-being and negative adjustment 
including psychological symptoms such as general mood disturbance, distress, anxiety and 
depression.  Quality of life was considered too broad a construct incorporating social in 
addition to psychological concepts and, therefore, studies investigating its measurement 
were excluded.  Finally, it was deemed important that studies investigated the association 
of emotional expression with psychological adjustment as opposed to its association 
relative to other coping styles.   In view of these considerations, all studies obtained via the 
electronic search were examined for inclusion in relation to the following criteria:  
Inclusion criteria   
1. Studies that include a cancer population (aged 18 years or over)  
2. Studies investigating an association between emotional expression and 
psychological adjustment  
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3. Studies which include a measure of emotional expression as an independent 
variable  
4. Studies which include a measure of psychological adjustment (e.g. 
depression/anxiety, mood disturbance, distress) as a dependent variable   
5. Studies published in a peer-reviewed journal article written in English 
 
Exclusion criteria  
1. Studies evaluating psychological interventions including emotional expression as a 
component which may impact on psychological adjustment to cancer 
2. Studies investigating emotional expression as a moderating or mediating variable 
between another construct and psychological adjustment. 
3. Studies investigating quality of life as a general concept 
4. Studies including emotional expression as a coping style compared to other coping 
styles as opposed to measuring levels of emotional expression   
5. Review articles, single case studies, dissertation abstracts, book chapters and 
conference proceedings  
 
Results 
 
The electronic search yielded a total of 1736 articles once duplicates were removed.  1432 
articles were deemed unsuitable and excluded on the basis of reading the title alone.  On 
reading the abstracts of the remaining 304 articles, a further 281 were excluded.  Full text 
articles of the resulting 23 studies that were potentially suitable for review were obtained, 
of which 15 met criteria for inclusion in this review (See Appendix 1.2 for articles 
excluded at this stage).    Reference and citation lists for these 15 articles were searched to 
ensure no appropriate studies had been missed.  Finally, the content‟s pages of key journals 
including Psycho-oncology and Health Psychology were hand searched and this also 
identified no further articles.  See Figure 1.1 for a description of the search process.  Of the 
15 articles considered for review, findings from the same cohorts were used in the three 
studies by Iwamitsu et al [27-29].   Owen et al and Cordova et al also reported findings 
drawn from the same research pool [30,31].  To be comprehensive, all studies will be 
included in the present review but will be reviewed together. 
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Assessment of methodological quality 
A quality rating scale was devised for the purpose of this review, using and adapting items 
from the SIGN 50: a guideline developer‟s handbook [32].  This scale covered the 
following areas: study aims and objectives, design, participant recruitment, outcome 
measurement, participant characteristics, statistical analysis and results (see Appendix 1.3).  
A score of 0, 1 and for certain items 2 could be allocated depending on the degree to which 
each aspect of methodology was met and a total of 21 points could be awarded.  Papers 
received a rating of “high” if 75% of this score was achieved; “medium” if between 50 and 
75% was obtained and “low” if less than 50% was acquired.    Articles reporting findings 
from the same cohort were considered together for a combined methodological quality 
rating to represent the study as a whole.   
 
Reliability of quality rating 
Fifty percent of studies were randomly selected and independently rated by another 
researcher using the same rating scale.  There was > 95% agreement between raters and 
discrepancies were resolved via a meeting to discuss and review disagreements.  
 
Review of findings 
Table 1.1 presents data extracted from each study to facilitate comparisons across study 
design, methodology, psychological construct and measurement, main findings and other 
aspects deemed important and relevant for the current review.  The narrative review below 
aims to provide an initial summary of the studies selected, followed by a distillation of the 
overall findings and a consideration of what each study contributes in reference to the 
research questions.  To avoid repetition, the studies utilising self-report to measure 
emotional expression will be considered followed by a separate section reviewing findings 
in relation to studies using other approaches. 
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Summary of studies  
The total sample size of the studies was 1281 (range of n =  21 – 359).  With regards to 
cancer type, nine studies focused on breast cancer patients, one study investigated a 
heterogeneous cancer population (mixed gender), one study confined its investigation to 
women with gynaecological cancers and one looked at female heterogeneous cancer 
“survivors”.  Thus only one study included males [30,31].  In terms of design, five studies 
were cross-sectional and seven included a longitudinal component.  The majority of the 
studies utilised self-report questionnaires to measure emotional expression, with one study 
using linguistic text analysis and one drawing on both methodologies.  Table 1.1 outlines 
the constructs of emotional expression and psychological adjustment referred to by each 
study.  Emotional expression was investigated as a general concept in ten of the studies 
with six also investigating the expression of separate emotions.  According to the criteria 
defined, six studies were rated as high with the remaining six rated as medium in quality.   
 
Associations between emotional expression and psychological adjustment 
Emotional expression  
The two studies investigating emotional expression found an association with 
psychological adjustment.     
Manne and colleagues [33] conducted a longitudinal study investigating the impact of 
positive emotional expressivity on psychological adaptation among women diagnosed with 
gynaecological cancers (see Table 1.1).  Having a stronger tendency toward positive 
emotional expressivity at baseline was associated with higher positive affect whilst a lower 
tendency was associated with more depressive symptoms.  Both effects remained stable 
throughout the subsequent 9 months in that although emotional expressiveness predicted 
initial psychological status, it did not predict rate of change in affect.  Further to being 
rated as high according to the quality rating scale, an additional strength of this study is 
that it looks at mental wellbeing as well as mental ill-health which the rest of the articles 
focus solely on.  Psychological adjustment has also been investigated over time rather than 
at one time point, acknowledging the dynamic nature of adjustment to this chronic disease 
with stressors in relation to both illness symptoms and treatment procedures.  A limitation 
is that the participants are drawn from a larger psychological intervention trial which may 
have resulted in a sample that was biased toward psychologically minded women who 
were more willing to participate in psychological interventions.  A methodological 
 23 
weakness common to all studies in this review is that no power calculation was used to 
justify the sample size obtained.  
In another longitudinal study, Stanton et al investigated psychological adjustment to breast 
cancer [34].  Greater use of coping through emotional expression, measured within 20 
weeks following medical treatment, was associated with lower psychological distress three 
months later.   Stanton et al‟s study was also rated as high, one of the strengths being that 
the authors statistically controlled for age, other coping strategies (e.g. avoidance, 
problem-focused coping, spiritual coping and seeking social support) and initial levels of 
psychological adjustment, with the significant effect remaining.  The authors acknowledge 
that the generalisability of these findings is limited to early stage breast cancer patients and 
to the period after termination of primary medical treatments.  The study also utilised a 
self-report measure that was not used in any of the other studies in this review leading to 
limitations in its comparability to other research findings.     
 
Emotional non-expression 
A total of six studies found an association between constructs of emotional non-expression 
and psychological adjustment, with two studies reporting no such relationship.   
As Table 1.1 shows, Watson et al‟s 1991 study investigating the association between 
emotional control, adjustment to cancer and levels of anxiety and depression in a sample of 
women recently diagnosed with breast cancer had the largest sample size of the studies 
selected for review and was rated as high [23].  Watson et al used the Courtald Emotional 
Control Scale (CECS), the Hospital Anxiety and Depression Scale (HADS) and the Mental 
Adjustment to Cancer Scale (MAC).  The CECS was developed with a population of 
patients awaiting breast biopsy.  It provides a total emotional control score in addition to 
separate indices of the control of anxiety, depression and anger [35].  The measure has 
been used extensively in cancer research with good psychometric properties demonstrated 
with this population (e.g. Schlatter et al [21], Classen et al [36], Owen et al [30], Ho et al 
[37], Iwamitsu et al[28] and Ando et al[38] in this review).  This leads to the advantage of 
being able to compare the outcomes in this report with results of other studies in this area.  
Indeed, as can be seen in Table 1.1, 8 of the 12 studies reported in this review used this 
measure.  The HADS has the benefit of being specifically designed for medical patients 
and has been validated for use with cancer populations and the MAC, as the name 
suggests, was developed and validated on a population with various cancer types.  Further 
to looking at associations between emotional control and the other two variables, it was 
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specifically hypothesised that there would be an association between emotional control and 
feelings of helplessness as measured by the MAC and that helplessness would, in turn, be 
associated with more symptoms of depression.  A tendency towards emotional control was 
indeed associated with helplessness and helplessness was associated with more symptoms 
of both depression and anxiety.   Higher levels of HADS anxiety were reported for high 
than for low emotional controllers, however this difference was not observed for the 
HADS depression scores lending some support for the role of helplessness in linking these 
two variables.  
Classen et al investigated the association of emotional control with psychological 
adjustment in a sample of women with metastatic or recurrent breast cancer finding higher 
levels of emotional control to be associated with greater mood disturbance [36].
 
 Although 
rated as high, with clearly defined study objectives and sampling and the use of 
psychometrically sound measures, the interpretation of the results of this study has its 
limits.  The study is of a cross-sectional design whereby no prediction is possible with 
regards to whether emotional inhibition predicts future adjustment.  A further 
methodological weakness is that, despite reporting a range of demographic and medical 
variables, none of these were considered as potential confounders in analysis.  There is also 
some confusion over the approach being used to measure emotional expression.  As Table 
1.1 indicates, the authors report that psychological adjustment is associated with 
expressing emotion, however, the CECS, which measures the extent to which individuals 
report controlling the expression of emotions, was used.  Although some items, which are 
reversed when calculating the emotional control score, do reflect emotional expression, 
there are only 5 such items out of 21, indicating a measure of emotional control.  It could 
be argued that a low score does not necessarily relate to active emotional expression which 
is implied by the authors.                
In the earliest study included in this review, Grassi and Molinari investigated the 
relationship between suppression of negative feelings and psychological reaction to cancer 
in a group of breast cancer patients pre-biopsy, a week after mastectomy and six months 
later [39].  The CECS was used to measure emotional suppression, implying that the 
authors consider this to be measuring the same construct. Table 1.1 shows this overlap is 
present throughout research in this field, with 5 other studies using the CECS to measure 
emotional suppression.  Indeed, the two terms are used interchangeably by the developers 
of the scale.  Emotional suppression measured before lump biopsy was correlated with 
both depression and hostility at six months.  No such associations were demonstrated at the 
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two earlier points at which psychological reaction was measured or with other 
psychological symptoms of anxiety and somatisation.  This study was rated medium, one 
of its weaknesses being that a number of potential confounding variables were not taken 
into account in analysis (e.g. stage of disease, prognosis and type of therapy).  
Interpretation of the results is further limited by a small sample size with only 12 
participants remaining at the final 6 month assessment stage.    
Iwamitsu et al investigated the relation between emotion suppression and emotional 
distress in breast cancer patients, like Grassi et al [39], at different points in the patient‟s 
journey (see Table 1.1) [27-29].  Iwamitsu et al split their sample into an emotional 
suppression and an emotional expression group with a cut-off being the median values for 
the total emotional control score of the CECS.  The emotional suppression group reported 
more depression and anger than the emotional expression group at first visit, after 
disclosure of diagnosis and at three months after discharge but not after operation.  This 
study was rated medium, being brought down by a lack of clarity in participant selection 
and characteristics reported.  One of its strengths, however, like Manne et al‟s study [33], 
was its exploration of the dynamic nature of adjustment to cancer and its influences.   For 
the emotional suppression group there were significant differences in the levels of distress 
between different points in time, whereas no such differences were found for the emotional 
expression group.  This indicates a different pattern of adjustment for the two groups.  It is 
also possible that inference could be made in terms of at what stage emotional suppression 
may be particularly detrimental to psychological adjustment and in turn, at what point any 
related intervention may be beneficial.   However, little is made of this finding and its 
potential implications in Iwamitsu et al‟s report.  This particular study was a section of an 
overall research programme comparing breast cancer patients with those whose tumour 
was discovered to be benign.  For this particular analysis, only fourteen breast cancer 
patients were included with seven in each group and caution should be made in 
generalising the significant effects found with such a small sample.  There is also some 
confusion in the approach to the construct of measuring emotional expression that is taken.  
Although the authors refer to findings in relation to emotional suppression, referring to the 
group with scores at the lower end of the CECS as “emotional expressers” could be 
misleading for the same reasons outlined in relation to Classen et al‟s study [36].   
In their study of emotional control in Chinese female cancer survivors, Ho and colleagues 
found that higher levels were associated with perceived stress, anxiety, depression, 
helplessness and anxious preoccupation [37].   Emotional control positively predicted 
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stress levels even after the effect of depressed mood was under control.  This study, rated 
as medium, was cross-sectional and as such no causal relationships can be implied.  Also, 
Ho et al did not account for any patient characteristics as potential confounders in their 
analysis despite the variability in age and type of cancer in the sample.  Although not 
longitudinal, a unique contribution this study makes is that it investigates “cancer 
survivors” who, defined by the inclusion criteria, have been disease free in the last 5 years.  
Some insight is therefore provided as to longer term adjustment of cancer sufferers.  
However, no information is provided as to how long the participants recruited have been 
disease free.     
Ando and colleagues measured breast cancer patients‟ negative emotional suppression 
prior to diagnosis to investigate to what extent it was predictive of psychological distress 
immediately after diagnosis [38].  Like Iwamitsu et al [27-29], Ando et al used the CECS 
to measure emotional suppression and the POMS for their outcome of psychological 
distress, however, no significant effect was found.  It is possible that this is due to 
differences in the use of the measure and analysis.  Ando et al used multiple regression 
analysis with CECS scores entered as possible predictors of total mood disturbance as 
opposed to exploring differences between groups on subscales of the POMS.  Also, there 
was a larger age range in Ando‟s study.  It is difficult to ascertain if any other differences 
lie in the sample characteristics between the two studies as little information is provided in 
Iwamtsu et al‟s report.  Ando et al‟s study was rated as medium.  One weakness was its 
lack of clarity in some areas.  For example, the measure of emotional suppression taken 
prior to diagnosis was taken at “their initial outpatient visit” to a breast clinic but there is 
no indication of at what stage patients are at in the diagnostic process at this point.  A 
further limit of the study in relation to the questions raised in this specific review is that 
psychological response was taken almost immediately after diagnosis which arguably 
represents a more transient affective response that might remit spontaneously as opposed to 
giving an indication of psychological adjustment per se.  Iwamitsu et al‟s study[27-29], 
while also taking measures at this time, was not limited to this one-off recording.  A 
strength of Ando et al‟s study was that it compared demographics of those taking part and 
those not, in an attempt to ensure that these potential biases were not evident in the sample 
studied.  Mantani et al‟s 2007 study below also accounted for this [24].   
Schlatter et al 2010 examined whether emotional suppression was predictive of mood 
states for breast cancer patients during chemotherapy for breast cancer [21].  Emotional 
suppression was again measured using the CECS, taken at one time point specified as 
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within 12 weeks of surgery and prior to the onset of chemotherapy.  Mood disturbance was 
then measured on a daily basis for the duration of four cycles of treatment (84 days).  
Measures of mood included anxiety (The Speilberger State-Trait Anxiety Inventory short 
form), anger (The measure of angry mood), and depression (The four-item version of the 
Centre for Epidemiological Studies Depression Scale).  No association was found between 
emotional suppression in general and any of these mood outcomes, however as discussed 
below, Schattler et al also investigated the relation between the suppression of specific 
emotions and mood, where associations were found to be significant.  Schattler et al‟s 
study was rated as high.  A strength, where a number of the studies in this review are 
lacking, is that it considered a number of potential confounding medical variables that 
could be associated with emotional suppression, including prognostic status and stage.  
However, it was interesting to note that none of these variables were found to be 
significantly associated with emotional suppression and their inclusion as covariates in the 
mixed linear model analyses did not alter the patterns of the findings.  One potential limit 
to the study was its use of one- to four-item measures of mood. However, with the multiple 
daily assessments being made, it was deemed unfeasible to use lengthier measures.  
Another caution, acknowledged by the authors themselves, is that the use of daily 
measures, whilst enhancing the potential sensitivity in detecting associations of emotional 
suppression with mood, may have increased focus on symptoms and mood in a way that 
could have impacted on the reports of their occurrence and intensity.  A further limit lies in 
the authors‟ use of the data collected.  Although variation in mood over time was explored, 
with anxious mood tending to be elevated at the onset of a cycle and decrease over the 
course of the cycle, no attempt was made to explore changes in mood in relation to 
suppression of emotion.         
The only study investigating the construct of alexithymia was Mantani et al‟s exploration 
into associations between alexithymia and anxiety and depression in postsurgical women 
with breast cancer [24].
 
 Rated as medium, this cross-sectional study utilised the 20-item 
Toronto Alexithymia Scale (TAS-20).  The TAS-20 includes items rated on a five-point 
scale with a three-factor structure relating to the construct of alexithymia: difficulty in 
identifying feelings; difficulty in describing feelings; externally oriented thinking.  It is 
highlighted by the authors that the TAS-20 has been demonstrated to have high construct 
validity and reliability.  Bringing the rating down, however, is that no reference is made to 
the reliability within this condition-specific population.  The Zung self-rating anxiety scale 
and Zung self-rating depression scale are used, again with no condition specific 
psychometric properties reported.  A high degree of alexithymia correlated with a high 
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degree of patient anxiety but was not related to depression.  Due to the cross-sectional 
nature of this study, it is not possible to determine whether the symptoms of alexithymia as 
measured by the TAS-20 indicate a trait like characteristic or what has been described as a 
“secondary” or  “reactive” alexithymia as a defensive reaction to a stressful event.         
 
Is the expression of different emotions differentially associated with psychological 
adjustment?  
Critique of individual articles is included elsewhere in this review and therefore studies 
investigating the expression of separate emotions will be considered together in this section 
with less reference to the detail of the studies.  All papers using self-report to investigate 
emotional expression confined their analysis to that of general emotional expression and 
therefore this section focuses on constructs relating to emotional non-expression.     
Suppression of anxiety  
A total of four studies reported on the associations between suppression of anxiety and 
psychological adjustment with inconsistent results.  Both Watson et al [23] and Ho et al 
[37] demonstrated significant associations between anxiety suppression and greater 
anxiety.  Conversely, Schlatter found that anxiety suppression was associated with lower 
reports of anxiety and Grassi et al found no significant associations between anxiety 
suppression and any psychological symptoms [21, 39].  Iwamitsu et al found that their 
anxiety suppression group did not differ significantly on levels of anxiety compared with 
the anxiety expression group but that they did score higher on the depression-dejection 
scale of the POMS at first visit, after diagnosis and three months after discharge [27-29].  
They also scored higher on the anger-hostility scale after diagnosis and after discharge and 
on the fatigue-inertia scale after diagnosis.     
Suppression of anger 
A confusing picture also emerged from the three studies reporting associations between 
suppression of anger and psychological adjustment.  Anger suppression was associated 
with higher depression in both Schlatter and Iwamitsu‟s studies[21, 27-29].  Iwamitsu et al 
also found that those who suppressed anger had significantly higher scores on the tension-
anxiety subscale of the POMS compared with those who expressed anger.  However, 
Grassi et al found a negative correlation between amount of anxiety and control of anger, 
before biopsy, in their study.  Finally, Grassi et al found that control of anger was 
significantly positively correlated with hostility [39].      
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Suppression of depression  
Finally, five studies investigated suppression of depression symptoms.  Both Ho et al and 
Watson et al reported significant associations between the control of depression and self-
report of levels of depression [23, 37].  Interestingly, Grassi found that whilst before 
biopsy control of depression was negatively correlated with amount of depression reported, 
one week after mastectomy, though not significant, there was a trend in the opposite 
direction [39].  Schattler et al found that suppression of depression was associated with 
higher anxiety and finally Iwamitsu et al found no difference between the depression 
suppression and depression expression groups on any measure of psychological adjustment 
[21,27-29].  
 
How do results of studies using self-report measures of emotional expression compare to 
those utilising other approaches to its measurement?     
Owen and colleagues conducted an interesting study investigating the relationship between 
self-report and linguistic indicators of emotional expression and how they both relate to 
adjustment to cancer [30, 31].  Their sample of individuals attending a community cancer 
support group completed the CECS and POMS as measures of emotional suppression and 
mood disturbance.  Participants were also invited to provide a written narrative about their 
cancer experience.  A computerised content analysis program developed by Pennebaker 
and Francis, named the Linguistic Inquiry and Word Count (LIWC) [40], was used to 
measure emotional expression in this narrative.  The program uses a word counting 
approach comparing each word or word stem identified in a text sample to each of 2,290 
words contained in content-specific dictionaries, including those relating to affective or 
emotional processes.  In justification of its use, Owen et al[30] report that LIWC has been 
shown to replicate a manual content analysis of breast and prostate cancer online 
discussion groups.  They also point to literature evidencing its use in studies demonstrating 
a link between emotional expression and improved physical health outcomes.  Moderate to 
strong positive correlations were demonstrated between scores on the CECS and POMS.  
However, the authors‟ hypothesis that individuals who self-report lower levels of 
emotional suppression would be more likely to evidence emotional expression in written 
cancer narratives was not observed.  Further, linguistic indicators of emotional expression 
were not significantly correlated with mood disturbance.   
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The reports by Cordova et al [31] and Owen et al [30] were rated as high overall.  A 
strength in this research lies in its attempt to compare two methods of analysing the 
construct of emotional expression.  The study was also methodologically sound with clear 
aims and hypotheses, a large sample size and consideration of confounding variables.  For 
example, demographic and other personal characteristics of those who chose to provide a 
written cancer narrative and those who did not provide a narrative were considered and the 
groups did not differ with respect to age, gender or indices of socioeconomic status and 
ethnicity, medical factors, time spent using the support group or primary study variables 
indicating that these factors are unlikely to have biased the results obtained.   
Lieberman and Goldstein also used the LIWC as a measure of emotional expression [41]. 
A measure of depression was completed by new members to a breast cancer internet based 
bulletin board.  After 6 months, the measure was repeated and messages during that time 
were collected and analysed for emotional content.  In concordance with Owen et al, initial 
analysis of negative emotions by themselves had no predictive validity for change in 
depression.  However, examining individual dimensions of negative emotional expression 
within the context of cancer, Lieberman et al found that greater expression of anger and 
sadness was associated with lower depression after six months.  Conversely, the more 
participants expressed anxiety, the higher were depressive scores after 6 months.  Rated as 
medium, one weakness of the study is no clear inclusion or exclusion criteria defined as to 
who was eligible for participation in the study.  Further, as is highlighted by the authors, 
the results are correlational and it is not possible to infer whether the expression of specific 
emotions is causing the changes in distress or rather a manifestation of these changes.  
However, the finding that emotional expression was not associated with depression at time 
1 shows that there is at least a degree of change occurring in association with emotional 
expression.         
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Discussion 
 
This review aimed to address the general question of whether there is an association 
between emotional expression and psychological adjustment in cancer patients. More 
specific enquiry was made regarding the concepts of emotional expression, the expression 
of separate emotions and the measurement of this construct.  Main conclusions in relation 
to these questions are made along with a consideration of limitations to the research 
reviewed, recommendations for future research and clinical implications.     
 
Associations between emotional expression and psychological adjustment 
The majority of studies found a significant association between emotional expression and 
psychological adjustment.  Including both those studies using self-report and those using 
linguistic indicators of emotional expression, a total of 10 studies found an association, 
with the direction of this relationship being consistent across studies. There was also some 
evidence for the change of the association of emotional expression with psychological 
adjustment over time with two studies indicating that emotional suppression was 
associated with psychological distress at 3 or 6 months follow-up but not shortly after an 
operation [27-29, 39].  Further, it was found that whereas variation in levels of distress 
over time emerged for Iwamitsu‟s group of “emotional suppression” patients, levels of 
distress remained constant for the “emotional expression” group.    
 
Relationships between the different concepts of emotional expression and their 
association with psychological adjustment 
Although the two studies finding no association were investigating emotional suppression, 
with the remainder of the studies using this construct finding an association with 
psychological adjustment it would appear that, based on the review of the studies included 
in this report, there are no apparent differences between the two main approaches to 
measuring emotional expression and its association with psychological adjustment: that is, 
attempts to suppress, inhibit or control emotional expression is linked to poorer 
psychological adjustment and the expression of emotions is associated with better 
adjustment.  The one study investigating the construct of alexithymia also found that this 
was associated with poorer psychological adjustment [24].  Despite the complex and 
diverse reasons behind a lack of emotional expression, be it a deficit, a deliberate effort to 
control the expression of emotions or some other mechanism that is perhaps less conscious, 
it would appear that it is associated with poorer psychological adjustment.  However, this 
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would be a bold statement to make with only three studies reporting a measurement of 
emotional expression, one of which using a measure of emotional control.  It should also 
be highlighted that even if this claim was proven valid, it is important to examine why 
people do not express their emotions, particularly in the development of psychological 
interventions based on this association.  Also, calculating combined effect sizes in their 
meta-analysis, Panagopoulou et al found a weak significant association between increases 
in psychological distress and emotional non-expression but that the inverse was not true for 
emotional expression [25]. 
 
Is the expression of different emotions differentially associated with psychological 
adjustment? 
With several studies finding the suppression of certain emotions but not others being 
linked with poorer psychological adjustment, there is at least some suggestion that there is 
a differential association at play.  Also of interest is that the suppression of one emotion 
has been linked to the report of another emotion.  For example, both Schlatter et al [21] 
and Iwamitsu et al [27-29] found anger suppression to be associated with depression.   
Although there are some consistencies in the findings, there are also disparities that cannot 
be ignored and as such no confident claims can be made that the suppression of one 
emotion is or is not linked to a particular psychological outcome.  One interesting finding 
was that Grassi et al [39] found that control of depression was correlated with lower 
depression before biopsy but the trend, although not significant, was in the different 
direction at a later stage, after mastectomy.  This implies a complex interplay between 
emotional expression and psychological adjustment which varies according to context and 
could also account for differences in findings across studies.  Another explanation for 
discrepancies in the findings could be in the scales used to measure constructs of 
psychological adjustment.  To illustrate, Ho et al [37] and Watson et al [23] both used the 
HADS to measure anxiety and were congruent in reporting an association between higher 
scores on this subscale and control of this emotion, also measured by the same scale.  The 
studies which did not report such outcomes utilised different measures of anxiety (see 
Table 1.1).  
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Studies using self-report measures of emotional expression compared to those utilising 
other approaches to its measurement 
With only two studies utilising measures other than self-report, there is a limit to the 
conclusions which can be drawn in relation to this final question.  However, Owen et al‟s 
[30, 31] finding that lower levels of emotional suppression according to self-report were 
not associated with evidence of higher levels of emotional expression in written narratives 
provides some considerations for the use of Pennebakers‟ LIWC in measuring emotional 
expression.  One possibility is that although a measure of emotional expression is obtained, 
it does not tap into the construct of emotional suppression.  This makes sense in that the 
conscious suppression of emotions as opposed to the mere lack of expression of emotions 
is likely to require some form of insight provided by the person being “observed” that 
would be brought about by self-report but not necessarily in LIWC.  Another interpretation 
is that perceptions of one‟s ability to regulate emotion through emotional expression in 
everyday situations is not relevant to how they might perform in the specific circumstances 
created in a narrative writing task.  Alternatively, linguistic indicators of emotional 
expression as measured by the LIWC are perhaps not sufficiently sensitive to detecting 
emotion expression in this population.  The latter argument is given weight by the finding 
that linguistic indicators in this study were not significantly correlated with mood 
disturbance, where this association is largely found elsewhere.   
It is difficult to compare directly the results of Lieberman‟s [41] study of the expression of 
separate emotions to those using self-report as the studies using self-report purport to be 
measuring emotional suppression of separate emotions.  It is interesting to note, however, 
that greater expression of anger as measured in this study was related to lower depression 
and greater control of anger was related to higher depression in two self-report studies.    
 
Critique of methodology in studies 
Studies varied in their methodological quality according to the rating used with half rated 
as high and the other half medium.  Promisingly no studies were rated as low.  In addition 
to weaknesses highlighted throughout this review (e.g. lack of consideration of 
confounding variables, justification of sample size), a number of limits were evident that 
the rating scale used was not sensitive to.  One of the weaknesses in this area of research is 
a heavy reliance on self-report in the literature and the potential problem of common 
method variance.  While these measures are important in gaining valuable information on 
individuals‟ perceptions of their expressions of emotions, there are certain cognitive 
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memory and social desirability biases in relation to their use.  As is indicated, there may be 
a discrepancy between this subjective perception and more objective measures.  It is thus 
difficult to ascertain the construct validity of such measures.  Moreover, Panagopoulou et 
al argue that it is difficult for respondents to distinguish between items referring to 
expressing and experiencing distress and the confounding effects become stronger when 
the levels of psychological distress are increased [25].  There is also a lack of clarity in 
reference to the conceptually distinct constructs of emotional expression, particularly 
where measures of emotional control were utilised in studies reporting on emotional 
expression as opposed to non-expression.  This prevents clear interpretation of findings in 
the literature as a whole.  Another limit is that, although seven of the twelve studies 
incorporated a longitudinal element to their design, no conclusions can be drawn with 
regards to long-term adjustment with the longest follow-up assessment made nine months 
after baseline.  Finally, a limit in terms of scope of the literature is the lack of investigation 
of emotional expression and its association with psychological adjustment in men with 
cancer.  Although Cordova et al [31] found no differences between men and women on 
emotional suppression and mood disturbance, it is noted that over 70% of the sample were 
females and further investigation with this population to replicate this finding is required to 
substantiate this claim.  These shortcomings lead to several suggestions for future research 
outlined in the Research Agenda below: 
 
Clinical implications 
 
 
Research Agenda:  
 Further research evaluating behavioural and other indices of emotional 
expression and their relation to self-report.  For example,  use of objective 
measures such as peer reports, behavioural coding of emotional expression 
in addition to further refinement of linguistic text analysis in cancer 
populations 
 Use of longitudinal studies with extended follow-up periods to investigate 
long term psychological adjustment in relation to emotional expression 
 Further research into the association between emotional expression and 
psychological adjustment at different time points over the course of 
diagnosis and treatment with larger sample sizes.   
 Expansion of research to include measurement of emotional expression and 
its association with psychological adjustment in men 
 Continued research into association between expression of separate 
emotions and adjustment 
   
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Clinical implications 
Despite limits relating to both the studies evaluated and the conclusions that can be drawn, 
there are certain implications for health professionals.  Encouraging and facilitating cancer 
patients to identify and express both negative and positive emotions is likely to improve 
psychological adjustment.   Indeed emotional expression is included as a component in 
interventions for cancer patients such as Adjuvent Psychological Therapy [42] and specific 
techniques such as expressive writing [43] have been used with this population [44, 45].  
Developments with other clinical populations such as the use of spoken emotional 
disclosure methods with rheumatoid arthritis [46] and the integration of expressive writing 
techniques with mindfulness/awareness techniques and exercises to help patients with 
chronic pain to identify, express and integrate emotions [47] could also be considered with 
cancer patients.   In targeting the facilitation of emotional expression, it may be beneficial 
for clinicians to focus on the specific emotions being suppressed and how this may be 
affecting their psychological adjustment.  In addition, it is worth considering the time 
points at which emotional suppression may be impacting negatively on psychological 
adjustment and to be aware that emotional expression may be associated with poor 
psychological adjustment several months after surgery even if it is not evident at an earlier 
stage.                   
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Lay Summary 
The main aim of this study was to investigate psychological characteristics in adults who 
experience sleepwalking or night terrors, otherwise known as nREM parasomnias.  A group of 
people who currently experience these events were compared to a group of people with insomnia 
and a group of “good sleepers” in a questionnaire based study.  Participants answered questions in 
relation to the following psychological responses: emotional inhibition; worry; rumination and 
arousability (i.e. how much they are aroused either physically or mentally in different situations).  
It was found that the group with nREM parasomnias experienced higher levels of all of these 
measures than the good sleepers.  Those with insomnia were also found to have higher levels on all 
of these measures apart from rumination.  Overall these findings mean that psychological factors 
may play a part in the presentation of sleep walking and night terrors and it is worth continuing to 
explore this in further research.  If findings like these are replicated in future research then, it is 
worth considering developing psychological interventions to help sufferers for whom such 
experiences are having a negative impact on their lives.      
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Abstract 
Background: Little is known about the psychological characteristics of adults presenting 
with nREM parasomnias.  Research indicates that a common factor associated with their 
onset is stress.  Early studies suggest that adults experiencing such phenomena may be 
emotionally inhibited but no research has directly investigated this.   Understanding of 
insomnia and its associated psychological factors is more developed with several studies 
finding a relationship with both worry and rumination.  The role of somatic and especially 
cognitive arousal has also been emphasised.               
 
Methods:  The present study aimed to investigate these psychological factors in adults who 
experience nREM parasomnias.   148 adults were recruited with the index group of interest 
being the nREM parasomnia (nREMp) group (n = 48), a parallel sleep disorder group of 
people with Insomnia (n = 50) and a control group of good sleepers (GS) (n = 50).  The 
three groups were compared for differences on self-report measures of emotional 
inhibition, worry, rumination and arousal.        
 
Results: Compared with the GS group, significantly higher levels on all psychological 
variables were reported by the nREMp group and on all but rumination by the Insomnia 
group.  The Insomnia group scored higher than the nREMp group on cognitive arousal 
with no other differences found between these two sleep disordered groups.     
 
Conclusions: Preliminary evidence is presented for the influence of psychological factors 
in nREM parasomnias.  Further studies are required to replicate and extend these findings.  
There are, however, implications for the development and evaluation of psychological 
interventions which could prove a viable alternative treatment option for such clients in 
clinical settings.        
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Introduction 
 
What are nREM parasomnias? 
The group of sleep disorders collectively known as parasomnias are characterised as 
undesirable physical or behavioural phenomena occurring during the sleep period.
1
 
Common parasomnias include those that occur in REM (Rapid Eye Movement) sleep such 
as nightmare disorder and REM sleep behaviour disorder, and Non REM (nREM) sleep-
arousal disorder.
1
  The present study focuses on nREM sleep-arousal disorders, also 
referred to as “nREM parasomnias”.  nREM parasomnias tend to arise from stages 3 and 4 
of nREM sleep (slow wave sleep) and during the first third of the sleep cycle.
2
  The 
episode generally occurs in the first half of the night and the individual has near-total or 
total amnesia following the event.
3
  The main phenomena within this category of 
parasomnia are night terrors and sleepwalking.
2
  Night or “sleep” terrors are episodes of 
extreme terror associated with intense vocalisation and body motility and high levels of 
autonomic discharge.
4
  The individual is completely fixated on this frightening experience 
and, whilst awareness is restricted as such, cannot be reassured.
5
  Sleepwalking or 
“somnambulism” is characterised by ambulatory activity during nREM sleep.  
Sleepwalking and night terrors have been reported in some cases to occur together.
6 
 
Night terrors and sleepwalking are described in the International Classification of Diseases 
(ICD-10) and the International Classification of Sleep Disorders (ICSD2).
7, 8
   More 
specific forms of nREM parasomnias have also been reported including sleep-related 
eating disorder and sleep sex.
2
     
 
Prevalence of nREM parasomnias 
Episodes of night terrors and sleepwalking are more common in children than adults and 
usually decrease in frequency with increasing age.
2
  However, their prevalence in adults 
has been found to be higher than is often assumed.
9
  In a study based on self-report data in 
a sample from the UK general population, Ohayon and colleagues found that night terrors 
were reported by 2.2% of participants and sleepwalking by 2% compared with recent 
estimates of a 14.5 and 39.8 % prevalence rate estimated for night terrors and sleep 
walking respectively in young children.
6,10
   No gender differences were indicated in 
Ohayon et al‟s study, however other studies have reported that sleepwalking is around 
twice as common in males compared to females.
5
  nREM parasomnias have also been 
found to have a genetic basis and familial pattern.  Specifically, the HLA gene DQBI has 
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been reported to be present in 35% of sleepwalkers compared to 13.3% of normal controls 
with the presence of nREM parasomnias in a first degree relative increasing the chances of 
developing the disorder by a factor of 10.
11
  
 
Why study nREM parasomnias? 
While the majority of people who experience nREM parasomnias will not come to the 
attention of researchers or sleep professionals, for some there is a great desire for help in 
reducing or eliminating their occurrence due to the distress and potential risk caused.  
Sleep can be interrupted which, as with other sleep disorders, leads to a disruption in 
daytime functioning.  Behaviour related to the disorder can also cause harm and 
inconvenience to the self and/or others, impacting significantly on the individual‟s quality 
of life. Those afflicted can engage in complex motor activities including attempting to 
unlock locks, cook, climb out of windows, drive and engage in physically violent acts 
against others. 
3,2 
(see Appendix 2.2 for case illustration).  In severe cases incidents of 
homicide, filicide and suicide have been reported.
9
  Increasingly, experts in the field of 
these disorders are asked to give their opinion in legal cases where violent or injurious 
behaviours have purported to have arisen from sleep.
12
   
 
Unfortunately, the evidence base for effective psychological and medical interventions is 
lacking.  In a recent systematic review, Harris and colleagues reported a great need for 
adequately powered randomised controlled trials of treatments to better inform clinicians.
13
 
In order to develop psychological interventions, there needs to be investigation into the 
characteristics of people experiencing these phenomena and the possible factors that may 
predispose, precipitate and perpetuate these behaviours.   
 
What do we know about nREM parsomnias and when they occur? 
A common factor found to be associated with the onset of nREM parasomnias is stress.
11
  
In Ohayon and colleagues‟ aforementioned study, the group who experienced nREM 
parasomnia reported higher rates of stressful life events and mental stress in the past year 
compared with those experiencing no such behaviour.
6
  Sleep deprivation and alcohol 
consumption have also been linked  to their occurrence.
11
   
There has been some investigation into a possible relationship between psychopathology 
and nREM parasomnias.  Interestingly, Kales and colleagues found more intense clinical 
manifestations and high levels of psychopathology in adult-onset sleepwalkers compared 
with adults who had been sleepwalkers in childhood.
14
  Ohayon found a high percentage of 
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subjects with nREM parasomnias had concurrent mood or anxiety disorders.  Specifically, 
mood disorders were found in 30.4% of those with night terrors and 14.6% with 
sleepwalking compared with only 5.7% in healthy subjects.
6
  
 
Crisp and colleagues investigated personality and psychoneurotic characteristics of adults 
with either sleepwalking or night terrors.  A normal psychological profile apart from 
exceptionally high scores on hysteria, was demonstrated in both groups and high anxiety 
scores in the night terrors group.
15
  Crisp notes that questions within the hysteria scale most 
often responded to positively by those with night terrors included items relating to being 
excessively emotional, but that few of these patients displayed such behaviour in 
wakefulness.
6
  In reviewing literature on night terrors, Carlson et al similarly point to a 
tendency of people with night terrors to “react with fear and apprehension and inhibit 
outward expression” (Carlson et al 1982, p462).16  Concurrent with this is the finding that 
sleepwalking and night terrors are more common in good, compliant children who do not 
show their emotions.
17
  These early suggestions about the potential importance of 
psychological factors have not been followed up in research.  For example, there has been 
no research directly investigating emotional expression in adults presenting with nREM 
parasomnias. 
 
Turning to insomnia 
When considering research into sleep disorders, one turns to the topic of insomnia and 
finds a greater understanding of its associated factors.  Increasing age, female gender, 
psychiatric, in particular anxiety and depression, and medical disorders are all consistently 
found to be risk factors for insomnia.
18
  As is the case with nREM parasomnias, various 
studies have shown that stressful life events are often associated with insomnia.  More 
specifically, Morin and colleagues reported that the frequency of daily minor stresses was 
comparable for good and poor sleepers but the perceived impact of those stressors was 
higher for insomniacs, suggesting that it is the appraisal process rather than stress itself that 
is implicated in the presentation of insomnia.
19 
 
Incorporating established links between insomnia and stress, a number of cognitive 
behavioural models concerning factors that predispose, precipitate and perpetuate insomnia 
have lead to the development of psychological interventions and subsequent outcome 
studies.  Harvey‟s cognitive model posits that, in the context of a life stressor cognitive 
arousal in the form of rumination and worry predisposes the individual to insomnia.  
Chronic insomnia can ensue with a shift in the content of cognitions to concerns regarding 
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the inability to sleep and consequences of sleep loss which, along with other cognitive 
processes such as selective attention for sleep-related threats and distorted perceptions of 
daytime deficits, serves to maintain insomnia.
20
  In support of this model, several studies 
have found an association between both rumination and worry and poor sleep.
21-23
  Other 
cognitive processes have also been implicated to have a role in insomnia.  For example, 
Vela-Bueno found emotional inhibition to act as a mediating factor between rumination 
and sleep quality.
24 
  
 
The central tenet in Harvey‟s model lies in cognitive arousal.  An alternative, 
neurocognitive model, delineates arousal along the three intersecting dimensions of 
somatic, cognitive and cortical arousal.
25
  Where somatic arousal is thought to be more 
characteristic of acute insomnia, increased cortical arousal is proposed to be a conditioned 
response occurring around sleep onset and/or during the sleep period following repeated 
pairings of sleep related stimuli with insomnia related wakefulness.  It is suggested that 
this cortical arousal acts as the biological precipitant to cognitive arousal in the context of 
chronic insomnia and contributes to sleep continuity disturbance through enhanced sensory 
processing, enhanced information processing and long term memory formation. Evidence 
for the role of somatic, or physiological, arousal comes from studies demonstrating higher 
metabolic rate and reduced heart-rate variability in patients with primary insomnia 
compared with good sleeper controls.
26,27
   Increased cortical arousal has been 
demonstrated by studies demonstrating increased nREM high frequency EEG in patients 
with insomnia and investigations using functional neuroimaging techniques demonstrating 
greater global cerebral glucose metabolism.
28,29
  
 
As opposed to hyperarousal, the psychobiological inhibition model of insomnia proposes 
that insomnia occurs in association with the failure to inhibit wakefulness.
30
  Cognitive 
phenomena thought to be implicated in this difficulty include an attentional bias towards 
automatic processes which in turn prevents perceptual and behavioural disengagement, and 
sleep effort.  Evidence in support of this model come from studies indicating that people 
with psychophysiological insomnia have been shown to exhibit heightened levels of 
attentional bias and effortful preoccupation with sleep.
31, 32
        
 
Psychological interventions, predominantly taking a Cognitive Behavioural Therapy 
(CBT) approach have used techniques based on the theoretical underpinnings outlined 
above such as stimulus control, cognitive restructuring and imagery and relaxation.
33
  A 
recent review of the evidence-base for psychological and behavioural interventions 
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reported that CBT produced reliable and sustained changes on several sleep parameters.
34
  
A meta-analysis by Riemann & Perlis concurs that psychological therapy produces 
improvements comparable to pharmacotherapy during the treatment period with the 
advantage of beneficial long-term effects.
35
    
  
Considering insomnia as a psychophysiological sleep disorder, in which cognitive and 
behavioural factors play key roles, has lead to much progress in the understanding of its 
aetiology and treatment.  The question arises as to whether the study of nREM 
parasomnias, also a psychophysiological disorder could be approached in a comparable 
manner.  Ohayon et al reported that their night terror group had significantly higher rates of 
psychophysiological insomnia than their group with no parasomnia (6.4% vs 1.9%).  
Although there was no such higher rate in the sleepwalking group (2.0%), this indicates 
some comorbidity between the two sleep disorders and perhaps some overlapping but 
distinct psychological mechanisms.
6
   
 
Aims and hypotheses 
Aims 
This study aimed to take into account what the literature offers thus far with regards to 
people who experience nREM parasomnias in conjunction with the more established 
research base on insomnia and its associations with psychological factors.  As such, an 
attempt is made to profile nREM parasomnias in relation to a number of the psychological 
variables introduced above, namely emotional inhibition, worry, rumination and arousal.  
A further objective was to explore any specificity of these variables to people experiencing 
nREM parasomnias relative to another sleep disordered group.   A controlled cross-
sectional study was conducted with the index group of interest being the nREM 
parasomnia group, a parallel sleep disorder group of people with insomnia and a control 
group of good sleepers. 
 
 Hypotheses 
The present study aimed to test the following hypotheses:  
 It was first hypothesised that, confirming findings from previous research, people 
with insomnia will have levels of a) Emotional inhibition, b) Worry, c) Rumination 
and d) Arousal that are elevated relative to good sleepers. 
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 It was secondly hypothesised that, relative to good sleepers, the group experiencing 
nREM parasomnia, also a psychophysiological disorder, will also have higher 
levels of: a) Emotional inhibition, b) Worry, c) Rumination and d) Arousal. 
 
Research questions 
It was not clear, however, whether there would be any differences on these variables 
between the nREM parasomnia and insomnia group and in what direction this may be.  
Therefore several research questions with regards to these two clinical groups emerged:    
 Are there differences between the insomnia and nREM parasomnia group in the 
nature or degree of a) Emotional inhibition, b) Worry, c) Rumination and d) 
Arousal? 
 
 
Methods 
 
Participants 
Participants were aged 18 and over, reporting English as their first language.  Allocation to 
the nREM parasomnia group and insomnia group was based on meeting criteria outlined in 
the (ICSD2) for nREM parasomnia and insomnia respectively.
8
 (see Appendix 2:3 for 
criteria).  To ensure that participants within the nREM parasomnia group could be defined 
as “currently” experiencing these phenomena, participants were also required to have 
experienced an episode within the past six months.  Criteria for admission to the control 
group were not meeting criteria for insomnia or nREM parasomnia and reporting 
satisfaction with the amount of sleep obtained.  
 
Conditions for exclusion included: Symptomatic evidence of another sleep disorder (e.g. 
sleep apnoea or periodic limb movement disorder); Sleep disturbance attributed to a 
psychiatric/medical condition or neurological disorder; significant drug or alcohol use. 
People meeting criteria for both nREM parasomnia and insomnia were excluded from the 
study. 
Approximately 300 people were spoken to about the study and a structured interview was 
administered to 239 of these people with 33 people being excluded at this stage for the 
following reasons: 11 people did not meet inclusion criteria for any of the group (i.e. did 
not experience insomnia or nREM parasomnia but did not report satisfaction with sleep); 
12 reported symptoms of another sleep disorder; 2 people met criteria for nREM 
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parasomnia and insomnia; 2 people did not speak English as their first language; 3 
experienced REM parasomnia (e.g. REM sleep behaviour disorder) as opposed to nREM 
parasomnia; 2 were deemed to be experiencing mental health difficulties which would 
impact on their ability to participate in the study; 1 person experienced insomnia due to 
being pregnant and 2 people had not encountered their nREM parasomnias within the last 6 
months.  Of the remaining 206 people who were given the questionnaire either in person, 
via email or sent in the post, 44 did not complete this.  Thus, 162 volunteers participated 
fully in the study.  Demographic information was collected with regards to participants‟ 
age, gender and postal address.       
 
Participant recruitment 
Participants were recruited via the University of Glasgow Sleep Centre‟s (UGSC) ongoing 
operational procedures.  As such, advertisements were placed on the UGSC website and 
posters displayed in GP surgeries and on University of Glasgow premises.  Participants 
who had not been suitable for previous studies at the UGSC but had agreed to be contacted 
for future studies were also identified.  Some participants were sourced through the 
parasomnia clinic at the UGSC.  Three sleep professionals working clinically with people 
with nREM parasomnia were contacted about the study and agreed to inform their clients 
about the study and distribute participant information sheets.       
 
The study was publicised via articles in national newspapers, social networking posts by 
the Mental Health Foundation (www.facebook.com/mentalhealthfoundation) and 
advertising at the Glasgow Science Centre.  Members of the public who had taken part in 
the Great British Sleep Survey (http://www.sleepio.com/survey/), indicating a presence of 
a nREM parasomnia, were informed about the study and invited to contact the researcher if 
they were interested in participating.   
 
This study was developed as part of a larger programme of research and suitable 
participants recruited into a parallel study investigating stress reactivity in people with 
nREM parasomnia, insomnia and good sleepers were offered the opportunity to take part in 
this study and vice versa.  Additional recruitment was achieved via social connections and 
colleagues of the researcher.  
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Research procedure 
People interested in participating in the study were invited to contact the UGSC by e-mail, 
telephone or face-to-face.  Potential participants were screened using the UGSC standard 
screening interview administered to all volunteers intending to be involved in research at 
the UGSC, with additional screening items in relation to criteria for nREM parasomnia and 
specific health and demographic questions (Appendix 2.4).  If deemed suitable, they were 
provided with a participant information sheet (Appendix 2.5) and a consent form 
(Appendix 2.6).  Depending on their preference, those who consented to taking part were 
then emailed a link to the online version (see Appendix 2.7 for image of site homepage) of 
the questionnaire or provided with the paper set of questionnaires either by post or in 
person. 
 
Study design 
The study consisted of a between-groups cross-sectional design with three groups: Adults 
with primary insomnia, nREM parasomnia (nREMp) and good sleepers (GS).  The primary 
independent variables in relation to the hypothesis outlined were participants‟ scores on 
self-report measures of emotional inhibition, rumination, worry and arousal.  Group was 
the main independent variable.   
 
Justification of sample size/Power calculation 
No previous studies investigating any of the constructs of arousal, emotional inhibition, 
worry and rumination in relation to a nREM parasomnia population could be identified on 
which to base an estimated effect size. However studies investigating insomnia groups 
compared to controls have yielded large effect sizes.  For example, using data from a study 
by Harvey & Greenall, an effect size of d=1.07 was found between an insomnia group and 
good sleepers on measures of worry, which would correspond to a large effect size 
according to Cohen‟s effect size conventions.23,36   In answering its final research question, 
the present study investigated possible differences between two clinical populations and it 
was deemed likely that sufficient power would be required to detect a more conservative, 
medium effect size.   A priori sample size calculations were conducted using the G*Power 
3 software program for an independent samples t-test (two-tailed).
37
  With a significance 
level set at 0.05, a standard power of 0.8 and a medium effect size of d=0.5, it was 
calculated that a sample size of 64 would be required in each group.  The researcher aimed 
to recruit up to 100 participants per group and it was expected that obtaining this sample 
size would be sufficient to detect any significant differences between the two clinical 
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groups, in addition to differences between the clinical and control groups.  It was 
anticipated that applying strict criteria for inclusion into the study and attempting to match 
the groups with regards to age and gender would also enhance the power of the study in 
detecting any existing effects
II
.  
 
Measures 
 
Demographic, screening, sleep and clinical measures  
Screening interview  
Participants were screened administering the generic UGSC intake interview with 
additional study specific questions.  Information gathered included age, postal address, 
weekly alcohol intake, drug use and medical history. (Appendix 2.4)  
 
Participants were asked questions based on criteria outlined in the ICSD-2 for nREM 
parasomnia and insomnia.  Those meeting criteria for either category of disorders were 
also asked questions with regards to the history and frequency of their sleep phenomena.     
 
To ensure the absence of another sleep disorder, the screening interview consists of a brief 
algorithm based on criteria for narcolepsy, sleep breathing disorder, restless leg 
syndrome/periodic limb movement syndrome, circadian rhythm sleep disorder and 
parasomnia (including REM parasomnias).
38
    
 
Sleep  
The Pittsburgh Sleep Quality Index (PSQI) was utilised to provide a quantitative measure 
of sleep disturbance in addition to the above interview.
39
  This self-report questionnaire 
measures estimated sleep quality and disturbance over 1 month.  A global PSQI score 
of >5 has a reported sensitivity of 89.6% and specificity of 86.5% in distinguishing those 
with clinically significant sleep disturbance from those without.  The PSQI has been shown 
to have a satisfactory level of internal consistency (α = 0.83).  
 
The Sleep Condition Indicator (SCI) was also employed.
40 
 The SCI is an unpublished self-
report measure based upon proposed DSM-5 sleep disorder criteria 
(http://www.dsm5.org/ProposedRevision/Pages/Sleep-WakeDisorders.aspx) which has 
been developed at the UGSC and for which data has thus far been collected on 12,000 
                                                 
II
 In practice matching was conducted post-hoc, as outlined in the sample characteristics section of the 
results, because all attempts were made to maximise attainment of the target sample size.  
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people.  Participants are asked to report on the pattern of their sleep over the past month in 
addition to the quality of their sleep, the impact any poor sleep has had on their life and the 
level of concern they have had about their sleep.  Questions about the history of sleep 
problems are also included.  The SCI has demonstrated good internal consistency (α = 
0.89).
40
 
 
An Impact of Poor Sleep Assessment was also used to confirm group allocation and covers 
six areas outlined in the DSM-5 proposed criteria for insomnia regarding the impact of 
sleep on daytime functioning 
41
Specifically questions are asked in relation to mood, energy, 
relationships, daytime sleepiness, concentration and functioning at work. 
 
 
Clinical 
The Depression Anxiety Stress Scales (21 items) (DASS21) is a 21-item self-report 
measure of depression, anxiety and stress and was selected because it includes a specific 
stress scale and takes a dimensional view of DAS symptoms
42
; appropriate because this 
study was designed to exclude people with clinical disorders.  Internal consistency for the 
scales are satisfactory with α=0.93 for the total scale, and α=0.88, α=0.82 and α=0.90 for 
the depression, anxiety and stress scales respectively.   
 
Outcome measures  
Emotional Inhibition 
Emotion Inhibition was assessed using the Emotion Inhibition Subscale of the Emotion 
Control Questionnaire (ECQ-EI).
43
 Participants were asked to rate 14 statements and 
situations as generally “true” or “false”.  E.g. “people find it difficult to tell if I‟m excited 
about something or not”.  The ECQ-EI has been shown to have good internal consistency 
(α=0.77) and test-retest reliability (r=0.71).    
 
The Acceptance & Action Questionnaire – II (AAQ-II) is a 7-item self-report questionnaire 
that measures psychological inflexibility and experiential avoidance.
44
  Developed within 
the context of Acceptance and Commitment Therapy, this relates to an attempt to alter the 
form, frequency or situational sensitivity of difficult private events (i.e. thoughts, feelings 
and physiological sensations).  E.g. “I worry about not being able to control my worries 
and feelings”.  This questionnaire also has good psychometric properties (α=0.84). 
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Rumination and Worry  
Rumination was assessed using The Rehearsal Subscale of the Emotion Control 
Questionnaire (ECQ-R).   Participants are asked to rate 14 statements and situations as 
generally “true” or “false”. E.g. “I get worked up just thinking about things that have upset 
me in the past”, “I remember things that upset me or make me angry for a long time 
afterward”.  The ECQ-R has been shown to have high internal consistency (α=0.86) and 
test re-test reliability (r=0.80).
43
  
 
Worry was measured using the Penn State Worry Questionnaire (PSWQ), a 16-item self-
report instrument which measures the trait of worry.
45
  Items include “I am always 
worrying about something” and “I have been a worrier all my life”.  The PSWQ has strong 
internal consistency (α=0.95) and test re-test reliability (r=0.93).   
 
Arousability 
Arousability was measured using the Arousal Predisposition Scale (APS).
46
  The APS is a 
12-item self-report measure of arousability demonstrated to have a split-half reliability of 
0.83 and to predict individual differences in physiological arousal.
46
  Examples of items 
are “I find that my heart keeps beating fast for a while after I have been “stirred up”” and 
“I get excited easily”. 
 
The Sleep Arousal Scale (SAS) was also utilised.
47
  The SAS is a 16-item self-report 
measure which comprises both cognitive and somatic manifestations of arousal.  
Participants are asked to rate how intensely they experience symptoms as they attempt to 
fall asleep or return to sleep.  Items include “Worry about falling asleep” (cognitive) and 
“Heart racing, pounding or beating irregularly” (somatic).  Internal consistency for 
cognitive (8 items) and somatic (8 items) are good (α=0.76 and α=0.81 respectively). (see 
Appendix 2.8 for all measures).      
 
Approach to data analysis 
Data were first summarised to provide descriptive statistics.  Preliminary analysis was 
conducted to check whether the three groups differed with respect to age, gender and 
socioeconomic status.  Before conducting formal analysis, all variables were inspected to 
see if assumptions for parametric analysis were met.  Normality of each distribution was 
checked using graphical and numerical methods with reference to skewness and kurtosis.  
Homogeneity of variance was assessed using Levene‟s test for equality of variances.  Data 
not meeting these assumptions were transformed using square root or logarithmic 
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transformations
48
, and where data could not be rectified, appropriate, equivalent non 
parametric tests were employed.             
 
To test the main hypotheses, group differences with regard to the dependent variables were 
analysed using one way analysis of variance (ANOVA).  Where significant effects were 
found, post hoc Bonferroni tests were used to identify associated between group 
differences. Subsequently, Bonferroni corrections were applied conservatively to see if 
effects remained significant upon controlling for multiple comparisons.  To investigate the 
impact of age as a covariate, analyses of covariance (ANCOVA) was also considered.  
However in each case, the main effect remained significant and so original ANOVA results 
are referred to throughout the text (see Appendix 2.9 for all post-hoc analysis and 
ANCOVA results).    
 
Internal consistency was ascertained for each dependent measure on the whole study 
sample, calculating Cronbach‟s alpha coefficient (α) for continuous data and Kuder-
Richardson formula 20 (KR20) for dichotomous data.         
  
Relationships between the variables were finally explored using correlations.  To 
investigate correlations between all dependent measures and the DASS subscales it was 
acknowledged that a substantial proportion of the data were not normally distributed and 
therefore a Spearman‟s rank order correlation coefficient was used.  For subsequent 
specific correlations where data were normally distributed, the more powerful Pearson‟s 
product moment correlation was calculated.      
 
Analyses were conducted using Statistical Package for Social Sciences (PASW 18) 
software package.  Due to the exploratory nature of this study, tests were two-tailed with 
significance set at criteria p < 0.05 unless otherwise specified.  
 
 
Ethical approval 
NHS ethical approval and R&D approval was obtained from the Greater Glasgow & Clyde 
West of Scotland Research Ethics Service (See Appendix 2.10 for copy of approval letter). 
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Results 
 
Sample characteristics 
162 eligible participants completed the study.  A disproportionate number of participants in 
the Good Sleeper group completed the study and therefore 12 of these were withdrawn 
from analysis to create more even sample sizes across groups.  It is important to highlight 
that this was process was conducted independent of scores on the outcome variables of the 
study.  In selecting data to remove, attempts were made to improve matching to the index 
sample of participants with nREM parasomnias with regards to gender and maintain close 
matching in age to this group, thus reducing unexplained variance.  For example, by 
removing 6 females and 6 males from the Good Sleeper group, the ratio of males to 
females in this group became closer to that of the nREM parasomnia group.  Participant‟s 
score on the PSQI was also considered in selecting participants for withdrawal, with 8 
participant‟s data removed taking into account their score of > 5 on this measure (see 
Appendix 2.11 for specific details concerning participants removed).  A final 148 
participants were included for analysis and, based on the diagnostic and inclusion criteria 
applied, 50 were categorised as Good Sleepers (GS), 50 had Insomnia and 48 had an 
nREM parasomnia (nREMp).  
 
Table 2.1 provides demographic details of the participants. The mean age across all 
participants was 38.9 years (SD= 14.14) with a total of 101 females and 47 males.  With 
regards to group differences in demographic data, ANOVA  and Bonferroni‟s post hoc test 
revealed that the Insomnia group was significantly older than both the nREMp (p<0.001) 
and GS groups (p< 0.001).  Therefore subsequent hypothesis testing was performed 
initially without a covariate (ANOVA) and repeated with age as a covariate (ANCOVA).  
There were no gender differences between groups (X
2
 = 2.650, p = 0.266).   
 
A total of 122 (82.43%) participants were based in Scotland, 22 lived in England (14.86%), 
2 (1.35%) were currently residing in Australia, 1 person (0.68 %) lived in Northern Ireland 
and 1 (0.68%) in Belgium
III
.  An indicator of socioeconomic status based on postcode was derived for participants 
living in Scotland and the groups did not differ significantly according to this index (X
2
 = 
                                                 
III
With the use of web-based recruitment it was not easily possible to restrict the sample to the UK.  
Participants residing outside the UK had contacted the UGSC upon viewing the centre‟s website or had 
been living in the UK when they initially found out about the study and subsequently moved abroad.  No 
active attempts to recruit overseas were made. 
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4.850, p=0.09) (see Appendix 2.12).
IV
  The mean number of units of alcohol consumed by 
the overall sample was 6.28 per week and intake did not differ significantly between 
groups [F(2,141) = 0.039, p=0.902].  Regular recreational drug use was not reported by 
any of the participants.   
 
All participants in the nREM parasomnia group had experienced either a night terror or 
sleepwalking in the past 6 months.  With regards to subtypes, 14 (29.2%) experienced 
sleepwalking, 24 (50 %) experienced night terrors and 10 (20.8%) experienced both 
phenomena.  Figure 2.1 presents information on the frequency with which people 
experienced their nREM parasomnia in the past 6 months.   Although several participants 
stated that this was variable, estimates ranged from at least once per night to twice in total 
within this time frame.  Participants were also asked the age at which they first experienced 
their nREM parasomnia, the details of which are presented in Figure 2.2.   
 
 
Figure 2.1  Frequency of nREM parasomnia episodes in past 6 months 
 
 
 
 
 
                                                 
IV
 It was not possible to convert English to Scottish deprivation scores.  An index based on Scottish data, 
being the largest sub-sample, therefore serve as a proxy to an indication of socioeconomic status of the 
study sample 
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Figure 2.2 Age experienced first nREM parasomnia episode 
 
 
 
 
 
 
 
 
 
 
 
 
 
In the Insomnia group, the average duration of sleep difficulties was 15.2 years (range 
0.1-50.9).  Of the 25 participants reporting to have had a problem for at least 11 years, 
10 reported that they did not “sleep okay as a child”, suggesting a more idiopathic form 
of primary insomnia.     
 
Sleep characteristics across groups  
The mean scores and standard deviations for each of the sleep measures are also 
presented in Table 2.1.  As expected, those in the GS group scored significantly lower 
than both the nREMp and Insomnia group in the PSQI, the SCI and the Impact of poor 
sleep questionnaire, confirming that they are good sleepers.  With regards to the two 
sleep disordered groups, those with insomnia scored significantly higher on the PSQI 
and on the SCI but there were no such significant differences in the Impact of poor sleep 
questionnaire.      
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Table 2.1 Demographic, sleep and clinical characteristics 
  
Measure GS nREM p Insomnia  F(2,145) P Post-hoc 
(N = 50) (N= 48) (N= 50 ) X2(2)   
Mean (SD) Mean (SD) Mean (SD)    
  
Age (years) 
36.54 
(11.6) 
32.37 
(11.6) 
47.56(14.5) 18.885 <0.001 I>nREMp=GS 
       
Alcohol  6.47 (5.84) 6.15(6.03) 6.21 (6.14) 0.039 0.902  
      
 
Gender: N (%) N(%) N(%)   
Male 15 (30) 12 (25) 20 (40) 2.65 0.266 
Female 35 (70) 36 (75) 30 (60)   
      
      
Sleep data: 
 Mean 
(SD) 
Mean (SD) Mean (SD)    
       
PSQI 2.80 (1.7) 7.21 (4.1) 12.02 (3.5) 113.912 <0.001 GS<nREMp<I 
       
SCI a  2.82 (5.7) 15.79 (7.1) 22.26 (5.7) 101.22 <0.001 GS<nREMp<I 
       
Impact of 
poor sleep 
2.06 (6.6) 11.29 (7.1) 13.32 (6.6) 77.805 <0.001 GS<nREMp=I 
       
Clinical 
data: 
      
       
DASS21a:       
Depression 1.24 (2.3) 8.17 (9.8) 9.32 (8.7) 42.165 <0.001 GS<nREMp=I 
       
Anxiety 0.94 (1.4) 7.17 (6.9) 6.68 (6.4) 55.299 <0.001 GS<nREMp=I 
       
Stress  4.76 (5.70) 12.50 (8.7) 15.04 (7.3) 47.871 <0.001 GS<nREMp=I 
       
a Kruskal-Wallis Test and Mann-Whitney Tests for post-hoc pairwise comparisons   
 
GS = Good Sleepers, NREMp = NREM parasomnia, I = Insomnia, PSQI = Pittsburgh 
Sleep Quality Index, SCI = Sleep Condition Indicator  
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Clinical characteristics across groups 
Table 2.1 also displays the clinical characteristics of each group as measured by the 
DASS21.  The GS group scored significantly lower on all three scales compared with 
both the Insomnia and nREMp group.  There were no significant differences between 
scores in the two sleep disordered groups on any of the scales.  It should be highlighted 
that the mean scores for each group fall within the normal and mild level severity 
categories of each scale of the DASS.
49
  Therefore although significant differences are 
evident between groups, these lie at the lower (likely subclinical) end of the scale and as 
such neither depression, anxiety or stress was considered as a covariate in subsequent 
testing of the main hypotheses (see Appendix 2.13) for a frequency count of participants 
in each severity category for the three DASS scales across groups).         
 
 
Hypothesis testing 
The descriptive statistics for each measure used in hypothesis testing are displayed in 
Table 2.2.  The nREM parasomnia and Insomnia groups were both hypothesised to have 
higher levels on all variables compared with the good sleepers with differences between 
the two sleep disordered groups remaining an open research question.  The results in 
relation to these hypotheses are presented separately for each variable below.   
 
Emotional Inhibition  
The mean scores and standard deviations on the Emotional Inhibition subscale of the 
ECQ are displayed for each group in Table 2.2 and presented graphically in Figure 2.3.  
It can be seen that, as hypothesised, both sleep disorder groups scored higher than the 
good sleepers on this scale.  A one-way ANOVA revealed a significant main effect 
between groups [F(2,145) = 7.508, p < 0.001].  Bonferroni‟s post-hoc analysis was 
conducted to clarify these differences.  Those within the nREMp group scored 
significantly higher than the GS group (P=0.001).  The Insomnia group also scored 
significantly higher than the GS group (P=0.01).  With regards to the research question 
concerning comparisons between the Insomnia and nREMp group, no significant 
differences were found (p=1).  The internal consistency of the Emotional Inhibition 
subscale was found to be high (KR20 = 0.81). 
 
Table 2.2 and Figure 2.3 also display the mean scores and standard deviations on the 
AAQ-II.  A one-way analysis of ranks (Kruskal-Wallis) was used to investigate 
differences between the three groups on this variable.  A significant group difference 
was found (X
2
 = 13.119, P < 0.001).  Subsequent pair-wise analysis using Mann-
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Whitney tests revealed that the Insomnia group scored significantly higher than the GS 
(p<0.001).  The nREMp scores were also significantly higher than the GS group 
(p<0.001), confirming the first two hypotheses.  Again, no such differences were found 
between the two clinical groups (p= 0.94). Internal consistency of the AAQ-II was 
demonstrated to be high (α = 0.81). 
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Table 2.2 – Outcome analysis  
       
Measure GS nREMp Insomnia F(2,145)    P Post – hoc 
N = 50 N = 48 N = 50 X2 (2)  
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
    
Emotional 
inhibition 
      
       
       
ECQ-EI  4.60(1.8) 5.92 (2.0) 5.70 (1.7) 7.508 0.001 nREMp=I>GS 
       
AAQ-II a 12.48(4.2)          19.31 (9.9) 19.24 (9.2) 13.119 0.001 nREMp=I>GS 
       
Rumination & 
Worry 
       
       
ECQ-R  4.42 (2.7) 7.23 (3.1) 5.86 (3.4) 10.053 <0.001 nREMp>GS 
       
       
       
PSWQb 
37.24 
(10.3) 
47.44 
(12.1) 
48.4 
(14.4) 
12.158 <0.001 nREMp=I>GS 
       
Arousability       
       
APS  28.66 (6.7) 34.25 (7.5) 32.42 (8.2) 7.08 0.001 nREMp=I>GS 
       
SAS cognitivea 13.4 (4.5) 18.73 (6.0) 25.28 (5.8) 70.201 <0.001 I>nREMp>GS 
SAS somatica 8.58 (1.0) 12.50 (4.5) 13.48 (4.2) 60.694 <0.001 nREMp=I>GS 
              
       
a
 Kruskal-Wallis Test with Mann-Whitney Tests for post-hoc pairwise comparisons   
 
b
 Data transformed using logarithmic transformation 
 
GS = Good Sleepers, nREMp = nREM parasomnia, I = Insomnia  
ECQ-EI = Emotional Control Questionnaire-Emotional Inhibition Subscale; AAQ-II = 
Acceptance & Action Questionnaire II; ECQ-R = Emotional Control Questionnaire 
Rehearsal Subscale; PSWQ = Penn State Worry Questionnaire; APS = Arousal 
Predisposition Scale; SAS cognitive = Sleep Arousal Scale cognitive subscale; SAS = 
Sleep Arousal Scale somatic scale 
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Figure 2.3. Mean scores and standard deviations for (a) ECQ-EI and (b) AAQ-II 
(a) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rumination and worry 
Rumination was measured by the Rehearsal subscale of the ECQ and mean scores and 
standard deviations are presented for each group in Table 2.2 and Figure 2.4.   Higher 
scores are evident in the 2 clinical groups.  A one-way ANOVA revealed a significant 
main effect between groups [F(2,145) = 10.053, p < 0.001].  Supporting the hypothesis 
that higher levels of rumination would be evident in those experiencing nREM 
parasomnia compared to good sleepers, a Bonferroni‟s post-hoc analysis revealed a 
significant difference between these two groups (p < 0.001).   No other significant 
(b) 
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group differences were uncovered.  However, the difference in means between the 
Insomnia and GS group represented a small to medium effect size of d=0.47.   A 
retrospective power analysis was calculated to determine what sample size would be 
required in each group to detect a meaningful difference should it exist.  With a 
significance level set at an α level of 0.05, a standard power of 0.8 (one-tailed), the 
number required was calculated to be 57.  Appendix 2.14 provides a tabular 
presentation of effect sizes and p-values revealed for all pair-wise comparisons 
indicating at what magnitude of effect significance is demonstrated.   Satisfactory 
internal consistency was demonstrated for the Rehearsal subscale (KR20 = 0.78).   
 
Mean scores and standard deviations are presented in Table 2.2 and Figure 2.4 for all 
three groups on the PSWQ.  A one-way ANOVA found a significant group effect [F 
(2,145) = 12.158, p<0.001].  It was hypothesised that both the Insomnia and nREMp 
group would score higher than the GS group and this was confirmed with Bonferroni‟s 
tests (p < 0.001 and p< 0.001 respectively).  In relation to the research question 
concerning the two sleep-disorder groups, no significant differences were revealed 
(p=1).  Internal consistency of the PSWQ was high (α = 0.93).    
 
 
Figure 2.4  Mean scores and standard deviations for (a) ECQ-R and (b) PSWQ 
 
(a) 
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(b) 
  
Arousal  
It was hypothesised that people in the insomnia and nREM parasomnia groups would 
report higher levels of arousal than good sleepers.  The question was also raised as to 
whether there would be any differences between the two sleep disordered groups on 
these measures. Table 2.2 and Figure 2.5 display the mean scores and standard 
deviations for the APS for each group.   A one-way ANOVA resulted in a significant 
group effect [F(2,145) = 7.080, p<0.001].  A post-hoc Bonferroni‟s test revealed that 
both the Insomnia and nREMp group scored higher than the GS group (p=0.04 and 
p=0.001 respectively).  However, applying Bonferroni‟s corrections, increasing the 
significance level to a more conservative p<0.017 the difference between the GS and 
Insomnia group no longer met significance. No significant differences were found 
between the two sleep disordered groups (p=0.69).  A high internal consistency of the 
APS was demonstrated (α = 0.84).      
  
Mean scores and standard deviations for the cognitive and somatic subscales of the SAS 
are also displayed in Table 2.2 and Figure 2.5.  The highest scores were found in the 
Insomnia group, this being particularly evident in the cognitive subscale.  Considering 
the cognitive subscale initially, a Kruskal-Wallis test indicated a significant group effect 
(X
2
 = 70.201, p< 0.001).  Pairwise analysis using Mann-Whitney tests showed that the 
Insomnia group were significantly more cognitively aroused than the GS (p <0.001), as 
were the nREMp group (p<0.001).  Those in the Insomnia group also scored 
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significantly higher than the nREMp group (p < 0.001) on this measure.  A significant 
group effect was also found on the somatic subscale (X
2
 = 60.694, p < 0.001) with both 
the Insomnia and nREMp group scoring significantly higher on this measure than the 
good sleepers (p < 0.001 and p < 0.001 respectively).  Although scores were higher on 
this subscale in the Insomnia group compared with the nREMp group, this difference 
was not found to be significant (p = 0.118).   Internal consistency of both the cognitive 
and somatic subscales were good (α = 0.89 and α = 0.78 respectively). 
  
Figure 2.5 Mean scores and standard deviations for (a) APS, (b) SAS cognitive & 
(c) SAS somatic  
(a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b) 
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Associations between dependent variables and DASS subscales  
Correlations were investigated between the dependent variable measures and each of the 
DASS subscales (see Appendix 2.15 for correlation matrix).  Significant correlations 
(P<0.001) were found between all measures indicating an association and potential 
overlap between some of the constructs being measured.  However, values for 
Spearman‟s rank order correlation coefficient were all within the low or moderate 
correlation ranges indicating that distinct psychological constructs are being measured.  
Interestingly, the lowest correlation was between the AAQ-II and ECQ-II scale (rs = 
0.303) whereby variability of scores on one questionnaire is accounted for by only 
9.18% of variability in the other.  The highest correlation was between the APS and the 
PSWQ (rs = 0.668) where approximately 45% of the variance of the former is explained 
by the latter.    
  
Associations between the PSQI and ECQ-EI   
Correlations between sleep quality and emotional inhibition as measured by the PSQI 
and the ECQ-EI were explored.  In line with the differences in scores on the ECQ-EI 
between the sleep disordered groups and the good sleepers, PSQI was found to be 
significantly positively correlated with ECQ-EI (r = 0.240, p<0.005).   
 
In consideration of the aforementioned differences between groups on each of the 
DASS subscales, the influence of these subscales on the relationship between the ECQ-
EI and the PSQI was investigated by conducting partial correlations, controlling for the 
effects of each subscale individually.  Indeed, the correlation between the PSQI and 
(c) 
(c) 
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ECQ-EI did not hold when the Depression, Anxiety and Stress subscales of the DASS 
were controlled for (r=0.075, p=0.18), indicating that the relationship could be due to 
this third factor.    
 
 
Discussion 
 
Little attention has been paid to psychological processes associated with nREM 
parasomnias, although stress is commonly associated with their expression, and there 
appears to be a higher prevalence of mood disorder, compared to healthy subjects.  
Expert opinion has also suggested that people with nREM parasomnias may be 
„emotionally inhibited‟.  By contrast, there is a relative wealth of research on insomnia, 
another sleep disorder of a psychophysiological nature which can be potentiated by 
stress.  Could it be that factors contributing to the development and maintenance of 
insomnia might also be implicated in nREM parasomnias?  The present study aimed to 
profile nREM parasomnias on a number of psychological variables, drawn from the 
limited literature on this particular disorder, as well as from the more established 
insomnia evidence base.  The main findings are discussed, followed by a consideration 
of the strengths and limitations of the study and its clinical and research implications.    
 
Insomnia: emotional inhibition, worry, rumination and arousal 
As hypothesised, the insomnia group reported higher levels on measures of emotional 
inhibition, worry and trait-like arousability in addition to cognitive and somatic pre-
sleep arousal.  The expected outcome of increased rumination, however was not 
established.   
 
The elevated levels of emotional inhibition, measured by the emotional inhibition 
subscale of the ECQ, compared with good sleepers, are concurrent with Vela-Bueno et 
al‟s finding of associations between emotional inhibition (using the same scale) and 
sleep quality.  It could be understood in the context of theories such as those proposed 
by Pennebaker who argues that emotional inhibition results in an increase in stress and 
intrusive, ruminative thoughts.
50
  It could be that it is its association with these factors 
that leads to an increased vulnerability to insomnia in the way that it has been proposed 
for other psychological difficulties.  The finding that this group scored higher on the 
AAQ-II, which specifically measures experiential avoidance, is in line with arguments 
for the use of mindfulness based techniques in addition to traditional CBT strategies in 
treating insomnia.  Increased experiential avoidance could involve controlled 
information processing strategies contributing to the inhibition of de-arousal proposed 
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in Espie‟s model of insomnia.51 This may be amenable to change through techniques 
endorsed in mindfulness approaches such as encouraging the acceptance of 
spontaneously occurring physiological and mental processes.
52
  There has been little 
prior use of this particular measure in insomnia populations with the exception of a 
study by McCracken et al in which associations were found with measures of sleep 
quality in chronic pain patients with insomnia.
53
   
 
Confirming findings from previous research, the higher levels of self-reported worry in 
the insomnia group, provide increased support for Harvey‟s aforementioned cognitive 
model which emphasises its role in insomnia.
23
   No such significant difference was 
found on the measure of rumination used, indicating that this related concept is perhaps 
not as predominant in insomnia.  However, retrospective power analysis showed a 
sample size of 57 would be required to detect a meaningful difference should it exist 
and it may be that the study was underpowered in this respect.   
 
Replicating findings of previous research into arousability, it was also found that those 
with insomnia reported more cognitive and somatic arousal compared with good 
sleepers.  With regards to the more trait like arousal predisposition scale, applying 
Bonferroni‟s corrections, increasing the significance level to a more conservative 
P<0.017, meant an initial significant difference on this measure was no longer present.  
It is recognised, however, that a trade-off exists between that of controlling the 
familywise error rate but increasing the risk of a type-II error and therefore the initial 
significance achieved should be not be discarded as uninformative. 
 
nREM parasomnia: emotional inhibition, worry, rumination and arousal 
With regards to hypotheses concerning the primary index group of interest, the 
participants experiencing nREM parasomnias reported significantly higher levels on all 
measurements of emotional inhibition, worry, rumination and arousability. 
 
The finding of higher levels of emotional inhibition relative to good sleepers is 
congruent with previous research pointing to this characteristic in people with nREM 
parasomnias.  It also provides empirical support to anecdotal reports from clinicians 
working therapeutically with this group (Espie, personal communication).  Such 
professionals have described clients with nREM parasomnias to have a tendency to 
cope well with stress at a surface level, appearing calm and in control but, that through 
therapeutic exploration, an underlying emotional vulnerability has emerged.  Use of the 
Emotional Inhibition subscale of the ECQ appears to have tapped into this notion with 
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items relating to remaining outwardly calm despite experiencing strong negative 
emotions and the concept of inhibiting the expressive elements of emotional 
experiences.  The mechanism by which emotional inhibition is associated with the 
occurrence of behaviours such as sleep walking requires further investigation.  Like, 
insomnia, however, it could be considered in relation to Pennebaker‟s theory that 
emotional inhibition is associated with increased stress.  It is proposed that the 
inhibition of expression of thoughts or feelings requires exertion that places a 
cumulative stress both on the mind and physiologically resulting in stress-related 
physical and psychological health difficulties.  Indeed, this is supported by early studies 
showing that both adults and children with emotional unexpressive tendencies are more 
physiologically reactive to emotional stimuli and later experimental research linking 
emotional suppression to increased autonomic arousal.
54,55
 
    
Participants with nREM parasomnias also scored higher on the AAQ-II.  This indicates 
that in addition to a tendency to inhibit the expression of emotions, experiential 
avoidance, referring to a more private construct relating to an individual‟s attempts to 
avoid the experience of undesirable internal events, could also be implicated in the 
presentation of nREM parsasomnias.  There has also been some research into emotional 
avoidance and physiological arousal.  Interestingly, elevated heart rate activity has been 
found in a “high experiential avoidance” group as measured by the AAQ compared to a 
“low experiential avoidance” group during neutral and resting baseline periods but not 
in response to unpleasant stimuli.
56,57
  It has been suggested that continuous attempts to 
regulate emotion leads to greater general levels of arousal.
57
  It could be suggested that 
emotional inhibition both in terms of its outward expression and experiential avoidance, 
is a factor contributing to the increased arousal levels demonstrated in the population in 
this study, presenting with these “disorders of arousal”.   
 
The suggestion that levels of rumination and worry might be elevated in people 
presenting with nREM parasomnias arose from evidence in relation to insomnia as 
opposed to any previous literature specific to this population.  That this hypothesis was 
confirmed indicates that, indeed, certain psychological factors implicated in insomnia 
also appear to be relevant to this sleep disorder.  It could be that such “persevarative” 
cognitions as rumination and worry in people with nREM parasomnias, like those 
experiencing insomnia, can be seen as a form of cognitive arousal which are also 
associated with sympathetic arousal.
58
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Both cognitive and somatic pre-sleep arousal and trait like arousability, all implicated in 
the development and maintenance of insomnia, were also found to be significantly 
higher in the nREM parasomnia group compared to good sleepers.  It could be 
postulated that, for example, a vulnerability to arousal developing for psychological 
reasons, such as those uncovered in this study, manifests itself through partial arousals 
out of slow wave sleep in the form of sleepwalking or night terrors.   
   
Although at this stage it is only possible to make suggestive statements about the 
mechanisms by which the factors reported in this study may be influencing the 
presentation of nREM parasomnia, the results at least suggest that, parallel to insomnia, 
there is a potential interaction between psychological and physiological processes at 
play.  
 
Differences between those with insomnia and nREM parasomnia 
A research question was posed regarding the specificity of the nature and degree of 
psychological measures to the nREM parasomnia group compared with the insomnia 
group.  The only significant difference uncovered was that of the insomnia group 
reporting higher levels of pre-sleep cognitive arousal than the nREM parasomnia group.  
In previous research, cognitive arousal has been consistently found to be more strongly 
associated with insomnia complaints than somatic arousal.
59,60
  It is interesting to note 
here that although both somatic and cognitive arousal was found to be higher in the 
nREM parasomnia group compared to good sleepers, the effect size for the difference in 
the somatic subscale was larger than for the cognitive subscale (Appendix 2.14).  It 
could be tentatively suggested that arousal is perhaps more evident in somatic, 
compared with cognitive, symptoms in this group, however more research would be 
required to explore this possibility. 
 
A key finding in this study is that the nREM parasomnia group were found to have 
levels of maladaptive psychological responses that were comparable to the insomnia 
group.  Despite their commonalities as psychophysiological disorders of sleep, however, 
there are distinct differences in how the sleep process is interfered with in insomnia and 
nREM parasomnias.  nREM parasomnias represent disorders of arousal from sleep 
rather than a difficulty initiating or maintaining sleep.  It is reasonable to suggest 
therefore that there would be some difference in the nature of psychological factors in 
this interference.  If this is the case, the measures used in this study were not sensitive to 
such differences.  Further theorising is needed with regards to where potential 
differences may lie between the two groups.  For example, perhaps there are distinct 
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vulnerabilities in relation to separate constructs of emotional inhibition whereby one 
may be more associated with a deficit in identifying and expressing emotions such as 
what is termed “alexithymia” and the other with a conscious emotion regulation 
strategy.       
 
Further theorising with regards to where potential differences may lie between people 
experiencing these two disorders and the selection of appropriate measurement in its 
investigation would help to enlighten this line of enquiry.  For example, utilising 
measures of separate constructs of emotional inhibition (e.g. in relation to a deficit vs a 
conscious emotion regulation strategy) may capture distinct vulnerabilities. 
 
The lack of disparity found on the psychological measures between the nREM 
parasomnia and insomnia groups in this study could also suggest that the same 
vulnerabilities are present within both sleep disorders but expressed differently.  People 
with insomnia experience a difficulty with down-regulating arousal.  A clear conscious 
self-perpetuating mechanism occurs whereby an individual‟s increased efforts to sleep 
paradoxically inhibits de-arousal and thus sleep.       
 
Perhaps in the case of nREM parasomnias, similar vulnerabilities, such as certain 
psychological responses to stress, manifest themselves in arousal from slow wave sleep.  
Unlike those with insomnia, however, due to some form of up-regulation or “anchor” 
into this stage of sleep, preventing the individual from fully wakening, this results in 
only partial arousal from sleep.  There could be some interaction here with specific 
factors implicated in deepening sleep or making arousal from sleep more difficult (e.g. 
sleep deprivation) which could further increase the chances of sleepwalking/night 
terrors (see Pressman, 2007 for a review).
11
  The types of behaviours that tend to occur, 
such as walking, eating and in some instances sexual activities, or in the case of night 
terrors, extreme reflexive emotions of fear, appear primitive in nature.  It could be 
postulated that while the primitive, subcortical part of the brain wakes up, other, higher 
functioning aspects of the brain remain in a sleep state.  The potential for parts of the 
brain being “awake” during sleep is in line with the notion of “local sleep”.  Contrary to 
the traditionally held view of the brain as a whole being in distinct states of awake, 
REM and nREM sleep, there is evidence to suggest that sleep is “local” in that at any 
one point in time, electrical markers of sleep can be restricted to certain areas of the 
brain.  Such evidence comes from research examining simultaneously recorded scalp 
EEG, intracerebral EEG, and unit firing in multiple brain regions of neurosurgical 
patients and studies of rats showing that, when kept awake beyond their normal sleep 
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time, neurons in different cortical areas can suddenly go „offline‟ in a way that 
resembles nREM sleep.
61,62
  Further research in this area could inform understanding of 
the neurological substrates of nREM parasomnias.   
 
Whereas the occurrence of insomnia increases with age, the opposite is found with 
nREM parasomnias, which are more common among children and usually “outgrown” 
during adolescence.  This typical developmental process could represent better 
integration of brain functioning and those individuals who maintain nREM parasomnia 
into adulthood may have a distinctive problem with arousal that is due to a lack of 
maturation in this respect.   
 
For people with insomnia, the cognitive processes implicated in perpetuating the 
disorder are incorporated into cognitive behavioural interventions with effective 
outcomes.  People experiencing nREM parasomnia have a much less active role in 
maintaining their disorder, however treatment focusing on intervening with the 
psychological mechanism that could be implicated in the expression of these behaviours 
such as those uncovered in this study could potentially result in elimination or at least 
reduction in their presentation.     Such an approach to intervention is considered below. 
 
Strengths and limitations 
One of the strengths of the study is the strict inclusion criteria that were applied in 
selecting participants, particularly in relation to the nREM parasomnia groups.  Each 
participant underwent a comprehensive screening interview, covering both diagnostic 
criteria for the specific nREM parasomnia reported and an algorithm to confirm no 
symptomatic evidence of another sleep disorder.  This added to the validity of the study 
in ensuring that it could be claimed with a high degree of confidence that those being 
studied did indeed experience this particular phenomenon.  For example, less rigorous 
procedures may have lead to the inclusion of people with other parasomnias such as 
REM sleep behaviour disorder which shares similar features.  Further, discrimination 
from an insomnia group enabled the exploration of possible psychological factors that 
may have been specific to nREM parasomnias as opposed to a sleep disorder per se.  
 
Some limitations, however, are important to outline when interpreting the findings in 
this study.  It should be acknowledged that this study was cross-sectional in design and 
therefore it is not possible to determine any causal relationship between nREM 
parasomnias and the psychological factors that were found to be associated with their 
occurrence.  Although it seems more plausible theoretically that such factors would 
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contribute to, rather than be a result of this phenomena, prospective studies would be 
required to have more confidence in this direction.  The study also relied solely on self-
report for measurements of its outcome variables which entail certain potential biases.  
It could be argued that people may not be able to give an accurate response due to 
cognitive and memory biases, thus measuring an individual‟s perception of a construct 
rather than measuring it directly.  Future studies could employ objective measures, for 
example of physiological arousal or alternative indices of emotional expression such as 
linguistic text analysis.           
 
Further limitations relate to the participants recruited.  The sample included both 
clinical cases and people from the general population.  It is possible that clinic 
attendees, for whom nREM parasomnias have caused sufficient disruption in their lives 
so as to seek professional help, may represent a qualitatively different population to 
those who experience nREM parasomnias with no such resulting impact.  Such variance 
in this group was not controlled for in this study. There was also no distinction made 
between adult onset nREM parasomnias and those who have experienced such 
phenomena since childhood.  Interestingly, the majority of participants in this study had 
experienced their first nREM parasomnia at least by their teenage year.  The finding 
that, compared to controls, this group displayed higher levels of psychological 
responses that are arguably maladaptive in nature, goes contrary to Kales‟ 
aforementioned report of more intense clinical manifestations in adult onset compared 
to child onset sleepwalkers.
14
  Finally, no attempt was made to investigate differences in 
subtypes of nREM parasomnias on any of the variables.  Including participants who 
experienced both types, 70% of this group experienced night terrors.  Therefore, without 
replication of these results with a greater representation of sleep walkers, there is the 
potential interpretation that the findings are indicative of night terrors as opposed to 
nREM parasomnias more generally.    
          
A final limitation when considering the generalisability of the findings in this study is 
the possibility of a type-II error.  The originality in the focus of this study, while a 
strength, meant there was limited information on which to determine a sample size to 
ensure any differences between the groups would be detected.  Although attempts were 
made to overcome this by aiming to recruit a large sample size of 100 per group in order 
to detect a small to medium effect size, this level of recruitment was not achieved.  
Indeed, where a retrospective power analysis calculation was performed with regards to 
rumination and insomnia, a sample size of only 57 was required to detect a difference 
should it be replicated.  It is possible that, should the targeted sample size have been 
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achieved, a significant effect would have ensued here, replicating previous findings of 
higher levels of rumination in this group compared to controls.  It should be noted, 
however, that  nonsignificant findings between the two sleep disordered groups were 
generally associated with very small effects sizes, thus increasing confidence that type 
II errors were  not committed in this respect.  Sample size was initially unequal across 
groups, with a disproportionate number of good sleepers.  In removing participants from 
this group to create more even numbers, the opportunity arose to improve matching to 
the nREM parasomnia group, particularly in relation to gender.  It should be noted that 
analysis was not re-run with the inclusion of the 12 participants who had been removed.  
The presence of unequal sample sizes between groups violates assumptions of certain 
statistical analysis and therefore it was considered that repeating the analysis with such 
violations could not be taken as validation of the analysis that was originally conducted.         
 
Implications 
Despite these limitations, the findings in this study provide some important initial 
evidence concerning psychological factors influencing the presentation of nREM 
parasomnias.  Previous research has provided evidence for biomedical predictors of the 
occurrence of such phenomena including sleep deprivation and alcohol consumption.  
The diagram presented in Figure 2.6 below represents a potential starting block on 
which further theory could be built.  The figure incorporates the psychological and 
physiological factors suggested by findings in this study to be influencing the 
presentation of nREM parasomnias, in addition to the biomedical and situational factors 
previously identified.  Further investigation is required into the interplay between these 
factors in contributing to this sleep disorder.  Much understanding of the aetiology and 
maintenance of insomnia has stemmed from psychologists drawing on models from 
other areas of psychology and clinical experience and investigating psychological 
processes in people with insomnia. The findings in this study suggest there may be 
value in approaching the study of people experiencing nREM parasomnias from the 
same perspective.       
 
If these findings are replicated, a greater emphasis on psychological intervention is 
implicated as opposed to restriction to the existing medical treatment and behavioural 
and risk management strategies that can be advised to such sufferers.  nREM 
parasomnias are an unpredictable, irregular phenomena and not an ideal model for 
corrective medication which is more suitable for regular symptoms.  Medication such as 
clonazepam and paroxetine have been reported to be effective for nREM parasomnias 
and can be taken as a preventative measure, despite a low probability of its 
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presentation.
38
  When considering medication as a treatment route, patients with nREM 
parasomnias have to weigh up the risks and benefits of such action and are often put off 
by potential side effects.  As is the case with insomnia sufferers, psychological 
interventions, should they prove effective, could present an appealing alternative 
treatment option.  There has been some promising development of psychological 
interventions in the area of parasomnias occurring during REM sleep such as 
nightmares.  CBT treatments here have focused on exposure technique such as writing 
down nightmares and imagery rehearsal in which the patient learns to rewrite and 
engage in imaginal rehearsal of a new version of their dreams which is not distressing.  
These techniques have proved to be effective in improving subjective sleep quality and 
reducing nightmare frequency and psychological distress.
63-65
       
 
Further research should involve building on the database thus far developed through this 
study, collecting data for more psychological measures on this client group.  This may 
include, for example, those relating to constructs of emotional expression such as 
measures of alexithymia, as discussed above, and measures of other coping styles, 
which may shed more light on how such people respond to stress.  Given its relative 
uncommonness, this would be facilitated by multi-centre collaboration.  If the particular 
psychological responses reported here are found to be replicated in future studies then 
interventions specific to these can be developed and evaluated.  In relation to tendencies 
toward emotional inhibition, expressive writing tasks may be of benefit, whereas 
general cognitive strategies such as cognitive restructuring may help to reduce worry 
(see Appendix 2.16 for structure of a Parasomnia Treatment Programme currently being 
piloted at the UGSC).   
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Figure 2.6 Biomedical, physiological, psychological and situational factors 
in nREM parasomnias 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusions 
Despite the limitations outlined, this study achieved its aim of providing some 
preliminary evidence for the implication of psychological factors in the presentation of 
nREM parasomnias.  People experiencing these phenomena were found to experience 
higher levels of emotional inhibition, worry, rumination and arousability relative to a 
control group of good sleepers.  With the exception of rumination, the study also 
confirmed and extended findings from previous research that those with insomnia also 
experience increased levels of these psychological variables relative to controls.  
Comparing the two sleep-disordered groups, it was found that the insomnia group 
reported higher levels of pre-sleep cognitive arousal.  This has been considered in line 
with evidence that cognitive arousal is more strongly associated with insomnia 
complaints than somatic arousal and is indicative of the self-perpetuating cognitive 
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processes that maintain them.  No other differences were uncovered and the 
implications of this was discussed with regards to the possibility that measures used in 
this study were not sensitive to any distinctive psychological processes that are present 
or that the same vulnerabilities are present in the two groups but are expressed 
differently.  It is suggested that further investigation into the interplay between 
psychological, physiological and biomedical factors in contributing to nREM 
parasomnias is warranted.  If the finding that psychological factors influence the 
presentation of this sleep disorder is replicated, weight is given to arguments for the 
development and evaluation of psychological interventions for such client groups, 
which could potentially provide them with an alternative, arguably preferable, treatment 
option to medication.          
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Abstract 
The catalyst for this reflective account was an interaction providing consultation to a 
community nurse.   This experience highlighted some insecurities and assumptions I 
had about justifying the unique contribution that I could bring to a team as a clinical 
psychologist.  Using aspects drawn from three models of reflection, I explore where this 
may have originated from and how my thoughts and feelings have changed with new 
learning experiences.    I refer to the relevant political drivers and policy documents that 
have influenced the ever evolving and multifaceted role of our profession.  I particularly 
consider the role of providing consultation to other professions, promoting 
psychological understanding in teams and how I can continue to develop this skill 
beyond qualification.   This seemed like a pertinent theme for the focus of the present 
account because as my skills and competencies have developed through the course of 
training, my understanding and perspectives have changed.  I conclude the account with 
a reflective review, considering what I have gained from the process of reflection itself 
and how I have found the models beneficial as a guide whilst not being restricted by 
rigid adherence to their structure.  I also critique how my reflections may have been 
improved and consider the importance of continuing to make time for structured 
reflective practice in my work.      
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Abstract 
As I approach the end of training I reflect on how to make that transition from trainee to 
qualified clinician.  I have observed those already in that role, inspired by the 
contribution they make on a regular basis to the functioning of the team and in 
increasing others‟ psychological knowledge through training and consultation.  I have 
chosen to focus this reflective account on what I have learned through these vicarious 
experiences.  I outline the context within which the direction of the clinical 
psychologist‟s role has moved towards undertaking these leadership tasks and describe 
two models that have guided my reflections.  Reflections were stimulated by my 
observation of a recently qualified clinical psychologist who provided consultation to a 
colleague and later considered how she might be able to do this more efficiently within 
the multidisciplinary team in which we work.  This brought to my awareness the 
apprehension I have previously had at the thought of being expected to fulfil leadership 
tasks at the early stages of my career.  I explore how my understanding of this has 
changed through such observations and my resultant feelings of excitement and 
eagerness to partake in these tasks in my future work.  I critique my approach to 
reflecting in this account and how I might improve future reflections by being more 
flexible in my approach.  I consider what I have gained through the process of reflecting 
on this particular topic and my thoughts in relation to the political context outlined 
earlier in the account.    
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APPENDIX 1.1 
Guidelines for submission to psycho-oncology 
Psycho-Oncology 
Manuscript Submission 
All papers must be submitted via the online system. 
Psycho-Oncology operates an online submission and peer reviewsystemthatallows authors to submit articles 
online and track their progress via a web interface. 
Please read the remainder of these instructions to authors and then click http://mc.manuscriptcentral.com/ponto 
navigate to the Psycho-Oncology online submission site, ScholarOne Manuscripts (formerly known as Manuscript 
Central). IMPORTANT: Please check whether you already have an account in the system before trying to create a new 
one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account 
created. 
File types. Preferred formats for the text and tables of your manuscript are .doc, .rtf, .ppt, .xls. LaTeX files may be 
submitted provided that an .eps or .pdf file is provided in addition to the source files. Figures may be provided in .tiff 
or .eps format. 
Please note: This journal does not accept Microsoft Word 2007 documents at this time. Please use Word's "Save As" 
option to save your document as a .doc file type. If you try to upload a Word 2007 document in ScholarOne 
Manuscripts you will be prompted to save .docx files as .doc files. 
Initial Submission 
Non-LaTeX Users: Upload your manuscript files. At this stage, further source files do not need to be uploaded. 
LaTeX Users: For reviewing purposes you should upload a single .pdf that you have generated from your source files. 
You must use the File Designation "Main Document" from the dropdown box. 
Revision Submission 
Non-LaTeX Users: Editable source files must be uploaded at this stage. Tables must be on separate pages after the 
reference list, and not be incorporated into the main text. Figures should be uploaded as separate figure files. 
LaTeX Users: When submitting your revision you must still upload a single .pdf that you have generated from your now 
revised source files. You must use the File Designation "Main Document" from the dropdown box. In addition you must 
upload your TeX source files. For all your source files you must use the File Designation "Supplemental Material not for 
review". Previous versions of uploaded documents must be deleted. If your manuscript is accepted for publication we 
will use the files you upload to typeset your article within a totally digital workflow. 
Copyright and Permissions 
Authors must sign, scan and upload to the online system: 
 a Copyright Transfer Agreement with original signature(s) - without this we are unable to accept the 
submission, and 
 permission grants - if the manuscript contains extracts, including illustrations, from other copyright works 
(including material from on-line or intranet sources) it is the author's responsibility to obtain written 
permission from the owners of the publishing rights to reproduce such extracts using the WileyPermission 
Request Form . 
The Copyright Transfer Form and the Permissions Form should be uploaded as "Supplementary files not for review" with 
the online submission of your article. 
 
If you do not have access to a scanner, further instructions will be given to you after acceptance of the manuscript.  
To enable the publisher to disseminate the author's work to the fullest extent, the author must sign aCopyright 
Transfer Agreement , transferring copyright in the article from the author to the publisher, and submit the original 
signed agreement with the article presented for publication. A copy of the agreement to be used (which may be 
photocopied) can be found in the first issue of the year on the Wiley Online Library website and through links in the 
online submission system. Copies may also be obtained from the journal editors or publisher. 
Submission of a manuscript will be held to imply that it contains original unpublished work and is not being submitted 
for publication elsewhere at the same time. Submitted material will not be returned to the author, unless specifically 
requested. 
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Manuscript style. The language of the journal is English. 12-point type in one of the standard fonts: Times, Helvetica, 
or Courier is preferred. It is not necessary to double-line space your manuscript. There should be a separate title page 
with full information and another page for an abstract, prior to the Introduction. Tables must be on separate pages 
after the reference list, and not be incorporated into the main text. Figures should be uploaded as separate figure files.  
 During the submission process you must enter the full title, short title of up to 70 characters and names and 
affiliations of all authors. Give the full address, including email, telephone and fax, of the author who is to check the 
proofs. 
 Include the name(s) of any sponsor(s) of the research contained in the paper, along with grant number(s) . 
 Enter an abstract of up to 250 words for all articles. An abstract is a concise summary of the whole paper, not just 
the conclusions, and is understandable without reference to the rest of the paper. It should contain no citation to 
other published work. Submit your abstract according to these headings: objective; methods; results; conclusions. 
 Include up to six keywords which must contain the words cancer and oncology that describe your paper for indexing 
purposes. 
 Research Articles should not exceed 4000 words (including no more than five figures and/or tables but excluding 
references). The limit for Brief Reports is 2000 words including no more than two tables or figures and no more than 
20 references. 
All abbreviations except for SI symbols should be written in full the first time they appear. Generic or clinical names 
should be used for all compounds: materials and products should be identified. The species of any animals used should 
be stated precisely. Sources of unusual materials and chemicals, and the manufacturer and model of equipment should 
be indicated. materials and products should be identified in the text followed by the trade name in brackets. 
Reference style. References should be cited in the text by number within square brackets and listed at the end of the 
paper in the order in which they appear in the text. All references must be complete and accurate. If necessary, cite 
unpublished or personal work in the text but do not include itin the reference list. Where possible the DOI for the 
reference should be included at the end of the reference. Online citations should include date of access. References 
should be listed in the following style: 
Decker, CL. Social support and adolescent cancer survivors: A review of the literature. Psycho-Oncol 2007; 16 : 1-11. 
Peterson AC, Leffert N. What is special about adolescence? In Psychosocial Disturbances in Young People: Challenges 
for Prevention, Rutter M (ed.).Cambridge University Press: Cambridge, 1997;3-36. 
Illustrations. Upload each figure as a separate file in either .tiff or .eps format, with the figure number and the top of 
the figure indicated. Compound figures e.g. 1a, b, c should be uploaded as one figure. Tints are not acceptable. 
Lettering must be of a reasonable size that would still be clearly legible upon reduction, and consistent within each 
figure and set of figures. Where a key to symbols is required, please include this in the artwork itself, not in the figure 
legend. All illustrations must be supplied at the correct resolution: 
Black and white and colour photos - 300 dpi 
Graphs, drawings, etc - 800 dpi preferred; 600 dpi minimum 
Combinations of photos and drawings (black and white and colour) - 500 dpi 
Tables should be part of the the main document and should be placed after the references. If the table is created in 
excel the file should be uploaded separately. 
Colour Policy. Where colour is necessary to the understanding of the figures, colour illustrations will be reproduced in 
the journal without charge to the author, at the Editor's discretion. 
Post Acceptance 
Further Information. For accepted manuscripts the publisher will supply proofs to the submitting author prior to 
publication. This stage is to be used only to correct errors that may have been introduced during the production 
process. Prompt return of the corrected proofs, preferably within two days of receipt, will minimise the risk of the paper 
being held over to a later issue. Free access to the final PDF offprint of your article will be available via Author 
Services only. Please therefore sign up for Author Services if you would like to access your article PDF offprint and 
enjoy the many benefits the service offers. 
Authors Resources: Manuscript now accepted for publication? 
If so, check out our suite of tools and services for authors and sign up for: 
Article Tracking 
E-mail Publication Alerts 
Personalization Tools 
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Cite EarlyView Articles 
To link to an article from the author's homepage, take the DOI (digital object identifier) and append it to 
"http://dx.doi.org/" as per following example: 
DOI 10.1002/hep.20941, becomes http://dx.doi.org/10.1002/hep.20941. 
To include the DOI in a citation to an article, simply append it to the reference as in the following example: 
Oestreicher, N., The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma, Cancer 10(1), pp. 
2054 - 2062, DOI: 10.1002/cncr.21464. 
Online Open 
OnlineOpen is available to authors of primary research articles who wish to make their article available to non-
subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With 
OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is 
made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding 
agency's preferred archive. For the full list of terms and conditions, 
seehttp://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms. 
Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our 
website at: https://onlinelibrary.wiley.com/onlineOpenOrder 
Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper 
OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go 
through the journal's standard peer-review process and will be accepted or rejected based on their own merit. 
Note to NIH Grantees 
Persuant to NIH mandate, Wiley-Blackwell will post accepted version of contributions authored by NIH grant-holders to 
PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For 
further information 
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APPENDIX 1.2 
Table presenting studies excluded on reading full article 
Study Reasons for exclusion 
Augustsdoftir et al 2010 Emotional expression investigated as a moderator 
variable 
   
Ando et al 2009 Investigating patients attending for screening, not 
necessarily diagnosed with cancer 
   
Hyphantis et al 2011 Investigating emotional expression compared to other 
coping strategies as opposed to levels of emotional 
expression 
   
Burns et al 2006 Emotional expression investigated as a moderator 
variable    
   
Hann et al 2008 “Breast cancer concerns” as opposed to psychological 
adjustment as outcome measure   
   
Harila et al 2011 Not measuring emotional expression as an independent 
variable 
   
Ripetti et al 2008 Quality of life measured as outcome,  psychological 
adjustment not analysed separately  
   
Verdonck-De Leeuw et al 2007 Investigating emotional expression compared to other 
coping strategies as opposed to levels of emotional 
expression   
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APPENDIX 1.3  
Methodological quality rating scale 
 
Quality Criteria 
Score  
0 1  2 
Study objectives… 
1) Are the study objectives clearly 
outlined? 
Neither aims or hypotheses stated = 
0 
Aims but not hypotheses stated = 1  
Aims and hypotheses stated = 2 
   
Study design ….. 
2) What is the design of the study?  
Cross-sectional design = 1  
Longitudinal element to design = 2  
   
Selection of participants… 
3) Are the inclusion/exclusion 
criteria clearly stated?  
Not reported = 0  
Referred to but not defined = 1  
Clearly defined =  2  
   
4) Is the recruitment process clearly 
described? 
Not reported = 0 
Partially reported = 1  
Clearly reported = 2  
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Participant characteristics … 
5) Are participant‟ characteristics 
clearly reported? (age, gender, 
socioeconomic status/ethnicity, 
cancer  type)  
None of the characteristics reported 
= 0  
Some characteristics reported = 1  
All characteristics reported = 2 
   
6) Are the main potential 
confounders identified and taken 
into account in the design and 
analysis?  
No = 0  
Yes = 1  
   
Independent variable 
measurement… 
7)How was emotional 
expression/non-expression 
measured?  
Non standardised self-
report/linguistic indicator measure 
(or details of psychological 
properties not reported) = 0 
Standardised self-report/measure of 
linguistic indicator with details of 
psychometric properties reported 
from other studies with different 
populations  = 1  
Standardised self-report/ measure of 
linguistic indicator with details of 
psychometric properties provided 
within the condition-specific 
population = 2  
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Outcome measurement…. 
8)How was psychological 
adjustment measured?  
Non standardised self-report 
measure (or details of psychological 
properties not reported)  = 0 
Standardised self-report measure 
with details of psychometric 
properties reported from other 
studies with different populations  = 
1  
Standardised self-report measure 
with details of psychometric 
properties provided within the 
condition-specific population = 2  
   
Statistical analysis and results…. 
9) Was a power calculation used to 
justify sample size?  
No = 0  
Yes = 1  
   
10) Was the statistical analysis 
stated clearly? 
Not stated = 0  
Stated but not appropriate to design 
= 1  
Stated and appropriate to design = 2   
   
11) Were results clearly reported, 
with confidence intervals, effect 
sizes, p-values etc provided where 
appropriate?  
Not reported =  0  
Partially reported = 1  
Fully reported  = 2  
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Quality rating:  
High = > 75%  
Medium = > 50%  
Low = < 50%  
 
Total Quality rating score  (out of a  possible 21 ) =  
Percentage =              %  
Quality Rating =  
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APENDIX 2.1 
Author Guidelines for submission to Sleep 
 
 
Full details at http://www.journalsleep.org/AuthorInfo.aspx 
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APENDIX 2.2 
 Case illustration of nREM parasomnia 
 
Case Example  
An 18 –year old white youth who resides in a rural Midwestern farming community is 
academically doing well as a senior in high school.  The patient reluctantly presented to 
the Sleep Center upon the insistence of his mother, who has had increasing concerns 
over her only child‟s safety, particularly at night.  According to his parents, since 
childhood their son has had nocturnal episodes arising within a few hours after sleep 
onset.  Believing that these would resolve as their son grew out of adolescence and into 
adulthood, the parents were at first not overly concerned and were able to maintain their 
son‟s safety by remaining vigilant and subtly intervening when necessary.  the patient‟s 
nocturnal activities have maintained their almost nightly regularity, but they have 
developed into occasionally more complex, sustained, and violent actions.  The patient 
has grown to 77 inches tall and a weight of 225 pounds, so it is not surprising that 
parental interventions to quell their son‟s suddenly unmanageable nocturnal activities 
have become problematic for both parties. 
 
The patient states that he has always been completely unaware of these episodes and has 
no recollection of the events the following morning.  The parents are further concerned 
for their son‟s safety because he intends to enrol in a college away from home and is 
looking forward to living in either a dormitory or a high-rise apartment.  Without the 
vigilance of responsible persons in college, the parents fear the worst for their son.  Of 
course the patient, wanting to exert his independence and lacking proper insight into the 
gravity of his situation, clearly had become antagonistic over his parents‟ concerns. 
 
The patient‟s continued lack of awareness in these matters coupled with his sincere 
denial of any difficulties with either sleep initiation or maintenance made the direct 
involvement of the patient‟s parents crucial in attaining a comprehensive history as well 
as a thorough clinical characterization of the patient‟s behaviour in sleep.  According to 
his mother, since childhood the patient has had “sleep disturbances” almost every night.  
Typically, these episodes occur within the first two hours after he has gone to bed, and 
only rarely do they occur in the latter third of the night.  The episodes are characterized 
by somniloquy, somnambulism, and a general “thrashing around in his bed,” leaving his 
bedding in complete disarray.  Less frequently, the patient would abruptly wake up the 
household with fits of “screaming and yelling at the top of his lungs.”  Despite his 
parent‟s efforts at reassurance and solace, the patient remained unreceptive and 
inconsolable.  Just as these “night terrors,” as the mother called them, came on 
suddenly, so too would they spontaneously abate. 
 
Although the patient‟s nocturnal activities were unremitting in frequency over recent 
years, his parents began to discern a trend toward more worrisome physical behaviour.  
These particular “severe” episodes were punctuated by violent outbursts of punching, 
hitting and kicking inflicted upon a foe in the room but unseen to his parents.  Never at 
any time were these combative actions directed towards his parents.  Many times over 
recent years the patient was caught trying to get out through the front door although he 
was visibly asleep.  On one occasion the mother caught her son just as he was 
attempting to leave through an upstairs window, having “already completely kicked out 
the storm window.”  In the last two years, it has not been uncommon for the patient to 
sustain bruises and superficial cuts to his extremities as a result of these nocturnal 
activities.  Lastly, the parents note that these “severe” episodes increase in frequency 
when the patient is staying away from home such as in a hotel or in summer camp. 
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Aside from a delayed form of delayed sleep-phase syndrome and consequent volitional 
sleep deprivation supported by three weeks of sleep diaries, the patient has otherwise 
been absolutely healthy and has not suffered from any medical, neurological or mental 
conditions.  The patient does not drink alcohol nor does he partake of illicit drugs. The 
patient does not take any prescribed medications, including selective serotonin reuptake 
inhibitors.  The patient does not have a history suggesting sleep-disordered breathing or 
any other primary sleep disorder.  Family history is devoid of any nocturnal behaviour 
suggestive of parasomnias. 
 
Formal nocturnal polysomnography was undertaken using a full seizure montage.  The 
baseline polysomnogram did not reveal any sleep-disordered breathing, nocturnal 
myoclonus or periodic limb movements.  Sleep architecture was within normal limits 
and the patient attained a sleep efficiency of 99%.  REM stage was attained and 
observed to have normal atonia.  A full seizure montage showed no electrical or clinical 
seizure activity.  Four discrete episodes of spontaneous NREM-related confusional 
arousals were observed and were associated with complex motor activity (fig 74-1) and 
overt vocalizations.  These confusional arousals were not associated with consequent 
EEG slowing.   
 
As suspected by the clinical history and further supported by the findings on the 
polysomnogram, the patient‟s problem was diagnosed as an NREM parasomnia.  The 
patient developed a better understanding of his problem after we replayed his findings 
on the video monitor.  Management strategies included: 
 
employing proper sleep hygiene and minimizing volitional sleep deprivation; 
continuing to refrain from or minimizing alcohol use; 
ensuring a supportive environment with appropriate responsible vigilance; provided by 
a team of family and friends; 
ensuring safety by, among other measures , attaining housing on the ground level or 
basement of his chosen residence; 
taking a long-acting sedative hypnotic of the benzodiapazine class every night. 
 
 
 
 
 
Copied from Mahowald, MW & Bornemann, MAC,  NREM Sleep-Arousal Parasomnias. In 
Kryger, MH, Roth T, Dement WC, eds.  Principles of Sleep Medicine, 4th edition. 
Philadelphia, PA: Elsevier Saunders; 2005: 889-896.   
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APPENDIX 2.3 
ICSD-2 Diagnostic Criteria for Insomnia and nREM Parasomnia Groups 
 
Participants in the insomnia group met the following criteria as described in the ICSD-2 
diagnostic classification system: 
 
General Criteria for Insomnia 
 
A. A complaint of difficulty initiating sleep, difficulty maintaining sleep, or waking up too 
early or sleep that is chronically non-restorative or poor in quality. 
B. The above sleep difficulty occurs despite adequate opportunity and circumstances for 
sleep. 
C. At least one of the following forms of daytime impairment related to the night time 
sleep difficulty is reported by the patient: 
i. Fatigue or malaise 
ii. Attention, concentration, or ,memory impairment 
iii. Social or vocational dysfunction 
iv. Mood disturbance or irritability 
v. Daytime sleepiness 
vi. Motivation, energy, or initiative reduction 
vii. Proneness for errors or accidents at work or while driving 
viii. Tension, headaches, or gastrointestinal symptoms in response to sleep loss 
ix. Concerns or worries about sleep 
 
Participants in the NREM parasomnia group met the following ICSD-2 diagnostic criteria 
for Disorders of Arousal (from NREM Sleep). 
 
Sleepwalking 
A. Ambulation occurs during sleep. 
B. Persistence of sleep, an altered state of consciousness, or impaired judgment during 
ambulation is demonstrated by at least one of the following: 
i. Difficulty in arousing the person 
ii. Mental confusion when awakened from an episode 
iii. Amnesia (complete or partial) from an episode 
iv. Routine behaviours that occur at inappropriate times 
v. Inappropriate or nonsensical behaviours 
vi. Dangerous or potentially dangerous behaviours 
C. The disturbance is not better explained by another sleep disorder, medical or 
neurological disorder, mental disorder, medication use, or substance use disorder. 
Night Terrors 
A. A sudden episode of terror occurs during sleep, usually initiated by a cry or loud scream 
that is accompanied by autonomic nervous system and behavioural manifestations of 
intense fear. 
B. At least one of the following associated features is present: 
i. Difficulty in arousing the person 
ii. Mental confusion when awakened from an episode 
iii. Amnesia (complete or partial) for the episode 
iv. Dangerous or potentially dangerous behaviours 
C. The disturbance is not better explained by another sleep disorder, medical or 
neurological disorder, mental disorder, medication use, or substance use disorder 
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APPENDIX 2.4 
UGSC Screening Interview 
 
Participant ref no:  
 
 
Today’s date:  
 
Source (to be answered by all participants) 
 
How did you find out about the University of 
Glasgow Sleep Centre? 
 
Why have you contacted us?  
Method of initial contact (e.g. mobile, email) 
 
 
 
Personal (to be answered by all participants) 
 
Full Name: 
 
Date of Birth: Age: 
Telephone (home, mobile): 
 
 
Address: 
 
 
 
 
 
Postcode: 
Email: 
 
When is a good time to call? 
What GP practice do you attend, and who is 
the GP you normally see? 
 
 
 
 
Do you give your consent for us to contact your 
GP if necessary regarding your health? 
 
 
 
Do you have difficulty sleeping at the moment? (Y/N) 
 
Are you generally satisfied with the amount of sleep you get (Y/N) 
Do you work shifts, night shifts? 
 
Are you aware of any other family members with a sleep disorder? 
 
If yes please specify: 
 
 
 
 
E.g. Do either of your parents have sleep difficulties (now or in the past)?  
What about brothers and sisters?  
What about extended family including grandparents?  
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Health (to be answered by all participants) 
Do you keep in good health physically? (Y/N) 
 
What physical health problems do you have (if applicable)? 
(Could your sleep difficulties be due to any other physical health problems or medication use?) 
What medicines do you take for your physical health? (if applicable) 
 
 
Roughly, how many units of alcohol do you drink per week?     
(Standard (175ml) glass of wine = 2 unit;  One pint of standard lager = 2.3  units;  Spirit & Mixer   = 
1 unit) 
 
 
 
Do you take recreational drugs? If so, how often? (e.g. once per week/month etc) 
 
Do you keep in good health mentally? (Y/N) 
 
What mental health  problems do you have (if applicable)? 
 
 
What medicines do you take for your mental health? (if applicable) 
 
 
 
 
Screen for Possible Sleep Disorders Other Than Insomnia.  
(to be answered by all participants) 
 
1. Narcolepsy 
a. Do you sometimes fall asleep in the daytime completely without warning? (YES/NO) 
If Yes…. 
b. Is it literally impossible to resist ‘sleep attacks’ during the day? 
c. Do you have collapses or extreme muscle weakness triggered by extreme emotion? 
d. Do you have visual hallucinations, either just as you fall asleep or when you wake in the morning? 
e. Are you paralysed and unable to move when you wake up from your sleep? 
 
[OFFICE USE ONLY: Possible narcolepsy: 1a¼‘‘TRUE’’ AND (1b OR 1c OR 1d OR 1e¼‘‘TRUE’’)]  
 
2. Sleep breathing disorder 
a. Are you a very heavy snorer? (YES/NO) 
If Yes… 
b. Does your partner say that you sometimes stop breathing? 
c. Do you often wake up gasping for a breath? 
d. Are you often excessively sleepy during the day or fall asleep without wanting to? 
 
[OFFICE USE ONLY: Possible sleep breathing disorder: 2a¼‘‘TRUE’’ AND (2b OR 2c OR 2d¼‘‘TRUE’’)] 
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3. PLMS/ RLS 
a. Do your legs often twitch or jerk or can’t keep still in bed?(YES/NO) 
If Yes… 
b. Is it very difficult to get to sleep because of repeated muscle jerks? 
c. Do you frequently wake from sleep with sudden jerky movements or with a compulsion to move your 
legs? 
d. Do you simply have to get out of bed and pace around to get rid of these feelings? 
 
[OFFICE USE ONLY: Possible PLMS/ RLS: 3a¼‘‘TRUE’’ AND (3b OR 3c OR 3d¼‘‘TRUE’’)] 
 
4. Circadian Rhythm Sleep Disorder 
a. Do you tend to sleep well but just at the ‘‘wrong times’’? (YES/NO) 
If Yes… 
b. Can you sleep well enough, but only if you stay up very late? 
c. Are you in a very sound sleep at normal waking time and could sleep on for hours more? 
d. Can you sleep well enough, but only if you go to bed very early? 
e. Do you wake very early, bright and alert and no longer sleepy? 
 
[OFFICE USE ONLY: Possible CRSD: 4a¼‘‘TRUE’’ AND EITHER (4b AND 4c¼‘‘TRUE’’) OR (4d AND 4e¼‘‘TRUE’’)] 
 
5. Parasomnia 
a. Do you have unusual behaviours, like sleepwalking,  associated with your sleep that trouble you 
or that are dangerous?(YES/NO) 
If Yes… 
b. Do you sleepwalk frequently and run the risk of injuring yourself or others? 
c. Do you have frequent night terrors when you are extremely distressed but not properly awake? 
d. Do you act out your dreams and risk injuring yourself or others? 
e. Do you have terrible recurring nightmares? 
 
[OFFICE USE ONLY:  Possible parasomnia: 5a¼‘‘TRUE’’ AND EITHER (5b OR 5c OR 5d OR 5e¼‘‘TRUE’’ 
 
If YES to b. or c. 
 Do you currently experience these?(YES/NO) 
 How often in the past 6 months? 
 
 
Insomnia (if applicable) 
Have you always been a poor sleeper? (Y/N) 
 
How long have you had a sleep problem?(yr) 
Do you have difficulty falling asleep? (Y/N)  
How many nights per week do you have difficulty falling asleep? (out of 7)  
How long does it normally take you to fall asleep?(min) 
 
Do you experience sleep disturbance because of waking during the night?(Y/N) 
How many nights per week do you have a difficulty with waking up during the night?(out of 7) 
How long are you normally awake during the night, in total? (min) 
 
What time do you normally go to bed? (time)  
What time do you normally get up?(time) 
 
How long do you normally sleep?(hr/min) 
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Sleepwalking (if applicable) 
Do you sleep walk or carry out any other activities during sleep.   Please describe any activities that 
occur in addition to walking (e.g. eating, sex, undressing/.dressing)? 
 
 
 
Is it difficult to arouse you from the sleep state during these events? 
 
Have you experienced mental confusion when awakened from an episode? 
Do you have any memory of such events upon awakening?  
How often do these events occur in general (e.g. once per week/once per month)? 
 
How many in last 6 months? 
How long ago did you last experience this event?   
Approximately how old were you when you first experienced an event like this?  
Do you know whether this occurs at the beginning, middle or end of your sleep?  
 
Night Terrors (if applicable) 
Do you experience sudden episodes of intense terror during sleep? 
 
Do you engage in any dangerous or potentially dangerous behaviours at these times? (if so, please 
describe) 
 
Do you have any memory of such events upon awakening?  
Is it difficult to arouse you from the sleep state during these events? 
Have you experienced mental confusion when awakened from an episode?  
How often do these events occur in general (e.g. once per week/once per month)? 
How long ago did you last experience this event?  
Approximately how old were you when you first experienced an event like this?  
Do you know whether this occurs at the beginning, middle or end of your sleep?  
 
All Sleep Disorders (to be answered by those with a sleep disorder) 
Does your sleep disturbance affect how you feel and function during the day (e.g. fatigue, sleepiness, 
concentration, memory, mood, motivation, irritable, work/social functioning etc.).  If yes, specify most 
salient.  
 
 
Other Studies (to be answered by all participants) 
We are also running a lab based study.  Would you be interested in being contacted about this study?  
If you are not suitable for any of the studies ongoing at the moment are you happy for your details to be kept on a 
database so that you may be contacted in the future should a suitable study start? 
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APPENDIX 2.5 
Participant Information Sheet 
      
  
PSYCHOLOGICAL PROCESSES IN ADULTS WITH NON-REM 
PARASOMNIAS, INSOMNIA AND GOOD SLEEPERS 
 
PARTICIPANT INFORMATION SHEET  
My name is Katherine Hooker.  I am a trainee clinical psychologist from the University 
of Glasgow working with Professor Colin A. Espie, Director of the University of 
Glasgow Sleep Centre.  I would like to invite you to take part in a study looking at 
psychological processes in people who experience sleep walking and night terrors 
which are sleep disorders collectively known as non-REM parasomnias.  The study will 
also be investigating these processes in people who suffer from insomnia as well as 
good sleepers.   
 
Before you decide whether or not to take part, it is important for you to understand why 
the research is being carried out and what it will involve.  Please take your time to read 
the following information carefully.  If there is anything that is unclear or if you would 
like more information, please let me know.  Take your time to decide whether or not 
you wish to take part.   
 
What is the title of this project?  
Rumination, worry, emotional inhibition & arousability in adults with non-REM 
parasomnias, insomnia & good sleepers 
 
Why is the study important?  
The current research investigating psychological processes in people with non-REM 
parasomnias (e.g. sleep walking, night terrors) is limited.  Comparing people with non-
REM parasomnias to those with Insomnia as well as good sleepers will help build on 
what we do know and may be relevant to developing appropriate treatments in this area.    
 
What are the aims of this study?  
The study aims to compare people with non-REM parasomnias with people suffering 
from insomnia and good sleepers on self-report measures of various psychological 
processes. 
 
Who can take part in this study?  
Men and women over the age of 18 who experience sleep walking or night terrors, 
suffer from insomnia or consider themselves to be satisfied with the amount of sleep 
they get.     
 
People who experience any other sleep disorder (for example, sleep apnoea or periodic 
limb movement disorder) will not be able to take part.  Those whose sleep disturbance 
is due to a psychiatric, medical or neurological condition will not be able to take part.  It 
will not be possible for somebody to take part if they experience both non-REM  
parasomnias AND insomnia.  People will not be able to take part if English is not their 
first language.  Those with significant drug or alcohol use will also be excluded. 
 
Do I have to take part?  
You do not have to take part in this study.  Participation is entirely voluntary.  If you do 
decide to take part you will be given this information sheet to keep and be asked to 
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sign a consent form.  If you decide to take part you are still free to come out of the study 
at any time without giving a reason.  
 
What does participation in this study involve?  
If you decide to take part, you will be given the option of doing so in one of the 
following ways depending on what is more convenient for you: 
 
 By completing a set of questionnaires which would be sent to you by post and 
can be returned in a stamped addressed envelope provided.  
 By completing this same set of questionnaires online via a website link that 
would be emailed to you. 
 By answering the same questions in an interview by arranging either a telephone 
call or a face-to-face interview at the University of Glasgow Sleep Centre. 
 
It usually takes approximately 20 minutes to complete this set of questionnaires.    
  
What will happen to all of the information?  
All of the information collected about you during the research study will be kept strictly 
confidential.  Personal details (such as your name and address) will not be stored on 
computer, so that you cannot be recognised from it.  If during the study a pre-existing 
but previously undiagnosed condition comes to light then your GP would be informed.  
 
Written feedback will be provided to those who request it following completion of the 
study. 
 
Who is supervising for this study?  
My research supervisor, Professor Colin Espie, who works for the University of 
Glasgow, will supervise me. 
 
Who is paying for this study?  
This study is being funded through the University of Glasgow and has been reviewed by 
a Research Ethics Committee.  The committee has approved the research as appropriate. 
 
What if something goes wrong? 
If you wish to complain, or have any concerns about any aspect of the way you have 
been approached or treated during the course of this study, you can contact my 
supervisor, Professor Colin Espie at the University of Glasgow (Tel: 0141 232 7699), 
who will be able to advise you on the appropriate complaints procedure, should you 
wish to use this. 
 
What should I do if I have any questions about this study?  
If you would like further details about the study, you can either contact me by phone or 
email.   
 
What do I do now if I want to take part in this study?  
If you decide that you would like to take part in the study you can either contact me on 
07788943028 or email glasgowsleepcentre@clinmed.gla.ac.uk.  If you decide you 
don‟t want to, there is no need to reply. 
 
You are under no obligation to take part; participation in this study is completely 
voluntary.  You do not have to give a reason for not wanting to take part in this study.   
 
I would like to take this opportunity to thank you for your time and consideration  
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APPENDIX 2.6 
 
Participant Consent Form 
 
 
 
 
 
 
 
 
 
Participant Identification Number:  
 
CONSENT FORM 
 
Title of Project: Rumination, worry, emotional inhibition & arousability in adults with 
NREM parasomnias, insomnia & good sleepers 
 
Name of Researcher: Katherine Hooker  
Please initial box  
 
1. I confirm that I have read and understand the information sheet dated 16th November 2010  
(version 2) for the above study. I have had the opportunity to consider the,  
 information, ask questions and have had these answered satisfactorily.  
 
2.  I understand that my participation is voluntary and that I am free to withdraw at any time  
without giving any reason, without my medical care or legal rights being affected.  
 
3.  I understand that data collected during the study may be looked at by individuals from the 
    University of Glasgow, from regulatory authorities or from the NHS Trust, where it is  
  relevant to my taking part in this research.  I give permission for these individuals to have 
  access to my records.  
 
 
4. I give consent for my GP to be contacted if an undiagnosed medical condition is suspected.  
 
 
5.  I agree to take part in the above study.  
 
_____________________ ________________  __________________________  
Name of Participant  Date    Signature  
 
 
_____________________  ________________  __________________________  
Name of Person   Date    Signature  
taking consent  
 
When completed, 1 for patient; 1 (original) for researcher site file 
 
 
 
 
 
 
University of Glasgow Sleep Centre 
Sachler Institute of Psychobiological 
Research  
Southern General Hospital 
Glasgow G51 4TF   
Tel: 0141 232 7699 
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APPENDIX 2.7 
Image of online survey site homepage 
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APPENDIX 2.8 
Measures 
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Sleep Condition Indicator 
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The Impact of Poor Sleep  
 
Over the last month to what extent has poor sleep troubled you in general?  
 
Not at all 
  
   A little 
 
 
 
   Somewhat 
  
Much 
  
  Very Much 
 
 
    
 
 
More specifically, to what extent has poor sleep affected……… 
 
…..your mood?     
 
 Not at all 
  
   A little 
 
 
 
   Somewhat 
  
Much 
  
  Very Much 
 
 
 
…..your energy? 
 
 Not at all 
  
   A little 
 
 
 
   Somewhat 
  
Much 
  
  Very Much 
 
 
 
…..your relationships? 
 
Not at all 
  
   A little 
 
 
 
   Somewhat 
  
Much 
  
  Very Much 
 
 
 
……your ability to stay awake during the day? 
 
 Not at all 
  
   A little 
 
 
 
   Somewhat 
  
Much 
  
  Very Much 
 
 
 
…….your concentration?  
 
 Not at all 
  
   A little 
 
 
 
   Somewhat 
  
Much 
  
  Very Much 
 
 
 
……..your ability to get through your work? 
 
 Not at all 
  
   A little 
 
 
 
   Somewhat 
  
Much 
  
  Very Much 
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ECQ: How we deal with our feelings 
 
 
 
Instructions: Please indicate how you feel about each item by circling either “True” or “False”.  If you 
feel that an item is neither entirely true nor false, please choose the alternative that is most like you.  If 
you haven‟t been in the situation described, please say how you feel you would behave in that situation. 
 
1. When someone upsets me, I try to hide my feelings.    True      False 
2. I remember things that upset me or make me angry for a long time afterwards. True      False 
3. People find it difficult to tell whether I‟m excited about something or not.  True      False 
4. I find it difficult to comfort people who have been upset.    True      False 
5. I generally don‟t bear a grudge – when something is over, it‟s over, and I don‟t True      False  
 think about it again. 
6. When something upsets me I prefer to talk to someone about it than to bottle it up. True      False 
7. I get “worked up” just thinking about things that have upset me in the past.  True      False 
8. If I receive bad news in front of others I usually try to hide how I feel.  True      False 
9. I seldom show how I feel about things.      True      False 
10. I often find myself thinking over and over about things that have made me angry. True      False 
11. If I‟m pleasantly surprised, I show immediately how pleased I am.   True      False 
12. If I get angry or upset I usually say how I feel.     True      False 
13. I can usually settle things quickly and be friendly again after an argument.  True      False 
14. I don‟t feel embarrassed about expressing my feelings.    True      False 
15. If I see or hear about an accident, I find myself thinking about something similar True      False 
 happening to me or to people close to me. 
16. I think about ways of getting back at people who have made me angry long after True      False 
 the event has happened. 
17. I never forget people making me angry or upset, even about small things.  True      False 
18. I think people show their feelings too easily.     True      False 
19. I find it hard to get thoughts about things that have upset me out of my mind. True      False 
20. I often daydream about situations where I‟m getting my own back at people. True      False 
21. Expressing my feelings makes me feel very vulnerable and anxious.  True      False 
22. If I see something that frightens or upsets me, the image of it stays in my mind  True      False 
 for a long time afterwards. 
23. Thinking about upsetting things just seems to keep them going, so I try to put  True      False 
 them out of my mind. 
24. I usually manage to remain outwardly calm, even though I may be churned up True      False  
 inside. 
25. If I lose out on something, I get over it quickly.     True      False 
26. I can‟t help showing how I feel, even when it isn‟t appropriate to do so.  True      False 
27. If I have to confront someone, I try not to think too much about it beforehand. True      False 
28. Sometimes I just can‟t control my feelings.     True      False 
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SLEEP AROUSAL SCALE (SAS)  (* = cognitive subscale items) 
 
Please describe how intensely you experience each of the symptoms mentioned below 
as you attempt to fall asleep or to return to sleep, by circling the appropriate number  
 
 Not at all Slightly Moderately A lot Extremely 
1.Worry about 
falling asleep*  
1 2 3 4 5 
2.Review or 
ponder the 
events of the 
day* 
1 2 3 4 5 
3.Depressing or 
anxious 
thoughts*  
1 2 3 4 5 
4.Worry about 
problems other 
than sleep*  
1 2 3 4 5 
5.Being mentally 
alert, active* 
1 2 3 4 5 
6.Can‟t shut off 
your thoughts* 
1 2 3 4 5 
7.Thoughts keep 
running through 
your head* 
1 2 3 4 5 
8.Being 
distracted by 
sounds, noise in 
the environment* 
1 2 3 4 5 
9.Heart racing, 
pounding or 
beating 
irregularly  
1 2 3 4 5 
10.A jittery, 
nervous feeling 
in your body 
1 2 3 4 5 
11.Shortness of 
breath or labored 
breathing  
1 2 3 4 5 
12.A tight, tense 
feeling in your 
muscles 
1 2 3 4 5 
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 Not at all Slightly Moderately A lot Extremely 
13.Cold feelings 
in your hands, 
feet or your body 
in general  
1 2 3 4 5 
14.Have stomach 
upset (knot or 
nervous feeling 
in stomach, 
heartburn, 
nausea, gas etc)  
1 2 3 4 5 
15.Perspiration 
in palms of your 
hands or other 
parts of your 
body 
1 2 3 4 5 
16.Dry feeling in 
mouth or throat  
1 2 3 4 5 
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APPENDIX 2.9 
Supplementary analysis: Post-hoc and ANCOVA 
Post-hoc analysis  
Sample characteristics: parametric  
Multiple Comparisons 
Age (years) 
Bonferroni 
(I) 1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia 
(J) 1=Good 
Sleeper; 
2=Insomnia; 
3=NREM 
Parasomnia 
Mean 
Difference 
(I-J) 
Std. 
Error Sig. 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Good Sleeper Insomnia -11.020
*
 2.536 .000 -17.16 -4.88 
NREM 
Parasomnia 
4.165 2.562 .319 -2.04 10.37 
Insomnia Good Sleeper 11.020
*
 2.536 .000 4.88 17.16 
NREM 
Parasomnia 
15.185
*
 2.562 .000 8.98 21.39 
NREM Parasomnia Good Sleeper -4.165 2.562 .319 -10.37 2.04 
Insomnia -15.185
*
 2.562 .000 -21.39 -8.98 
*. The mean difference is significant at the 0.05 level. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 122 
 
Sleep and clinical data: Parametric  
  
 
 
Sleep and clinical data: non-parametric post-hoc pairwise comparisons (Mann-
Whitney)  
 
Ranks 
 1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia N Mean Rank Sum of Ranks 
SCI Score = 1a + 1b + 1c + 
2 + 3a + 3b + 4 + 5 only  (0 - 
32) 
Good Sleeper 50 25.71 1285.50 
Insomnia 50 75.29 3764.50 
Total 100   
 
Multiple Comparisons 
Bonferroni 
Dependent 
Variable 
(I) 1=Good 
Sleeper; 
2=Insomnia; 
3=NREM 
Parasomnia 
(J) 1=Good 
Sleeper; 
2=Insomnia; 
3=NREM 
Parasomnia 
Mean 
Difference 
(I-J) 
Std. 
Error Sig. 
97.5% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
PSQItransformed Good Sleeper Insomnia -1.86616
*
 .12387 .000 -2.1975 -1.5348 
NREM 
Parasomnia 
-1.02129
*
 .12515 .000 -1.3561 -.6865 
Insomnia Good Sleeper 1.86616
*
 .12387 .000 1.5348 2.1975 
NREM 
Parasomnia 
.84487
*
 .12515 .000 .5101 1.1796 
NREM 
Parasomnia 
Good Sleeper 1.02129
*
 .12515 .000 .6865 1.3561 
Insomnia -.84487
*
 .12515 .000 -1.1796 -.5101 
Impacttransformed Good Sleeper Insomnia -2.56299
*
 .22152 .000 -3.1556 -1.9704 
NREM 
Parasomnia 
-2.18849
*
 .22382 .000 -2.7872 -1.5898 
Insomnia Good Sleeper 2.56299
*
 .22152 .000 1.9704 3.1556 
NREM 
Parasomnia 
.37451 .22382 .289 -.2242 .9732 
NREM 
Parasomnia 
Good Sleeper 2.18849
*
 .22382 .000 1.5898 2.7872 
Insomnia -.37451 .22382 .289 -.9732 .2242 
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Test Statistics
a
 
 
SCI Score = 1a 
+ 1b + 1c + 2 + 
3a + 3b + 4 + 5 
only  (0 - 32) 
Mann-Whitney U 10.500 
Wilcoxon W 1285.500 
Z -8.577 
Asymp. Sig. (2-tailed) .000 
a. Grouping Variable: 1=Good Sleeper; 
2=Insomnia; 3=NREM Parasomnia 
 
 
Ranks 
 1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia N Mean Rank Sum of Ranks 
SCI Score = 1a + 1b + 1c + 
2 + 3a + 3b + 4 + 5 only  (0 - 
32) 
Insomnia 50 62.66 3133.00 
NREM Parasomnia 48 35.79 1718.00 
Total 98   
 
 
Test Statistics
a
 
 
SCI Score = 1a 
+ 1b + 1c + 2 + 
3a + 3b + 4 + 5 
only  (0 - 32) 
Mann-Whitney U 542.000 
Wilcoxon W 1718.000 
Z -4.684 
Asymp. Sig. (2-tailed) .000 
 
 
Ranks 
 1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia N Mean Rank Sum of Ranks 
SCI Score = 1a + 1b + 1c + 
2 + 3a + 3b + 4 + 5 only  (0 - 
32) 
Good Sleeper 50 27.52 1376.00 
NREM Parasomnia 48 72.40 3475.00 
Total 98   
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Test Statistics
a
 
 
SCI Score = 1a 
+ 1b + 1c + 2 + 
3a + 3b + 4 + 5 
only  (0 - 32) 
Mann-Whitney U 101.000 
Wilcoxon W 1376.000 
Z -7.842 
Asymp. Sig. (2-tailed) .000 
a. Grouping Variable: 1=Good Sleeper; 
2=Insomnia; 3=NREM Parasomnia 
 
 
Ranks 
 1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia N Mean Rank Sum of Ranks 
DASS Depression Score Good Sleeper 50 33.70 1685.00 
Insomnia 50 67.30 3365.00 
Total 100   
DASS Anxiety Score Good Sleeper 50 31.11 1555.50 
Insomnia 50 69.89 3494.50 
Total 100   
DASS Stress Score Good Sleeper 50 32.04 1602.00 
Insomnia 50 68.96 3448.00 
Total 100   
 
 
Test Statistics
a
 
 
DASS 
Depression 
Score 
DASS Anxiety 
Score 
DASS Stress 
Score 
Mann-Whitney U 410.000 280.500 327.000 
Wilcoxon W 1685.000 1555.500 1602.000 
Z -6.033 -6.896 -6.403 
Asymp. Sig. (2-tailed) .000 .000 .000 
a. Grouping Variable: 1=Good Sleeper; 2=Insomnia; 3=NREM Parasomnia 
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Ranks 
 1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia N Mean Rank Sum of Ranks 
DASS Depression Score Good Sleeper 50 35.45 1772.50 
NREM Parasomnia 48 64.14 3078.50 
Total 98   
DASS Anxiety Score Good Sleeper 50 32.96 1648.00 
NREM Parasomnia 48 66.73 3203.00 
Total 98   
DASS Stress Score Good Sleeper 50 35.15 1757.50 
NREM Parasomnia 48 64.45 3093.50 
Total 98   
 
 
Test Statistics
a
 
 
DASS 
Depression 
Score 
DASS Anxiety 
Score 
DASS Stress 
Score 
Mann-Whitney U 497.500 373.000 482.500 
Wilcoxon W 1772.500 1648.000 1757.500 
Z -5.241 -6.116 -5.144 
Asymp. Sig. (2-tailed) .000 .000 .000 
a. Grouping Variable: 1=Good Sleeper; 2=Insomnia; 3=NREM Parasomnia 
 
Ranks 
 1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia N Mean Rank Sum of Ranks 
DASS Depression Score Insomnia 50 52.62 2631.00 
NREM Parasomnia 48 46.25 2220.00 
Total 98   
DASS Anxiety Score Insomnia 50 49.06 2453.00 
NREM Parasomnia 48 49.96 2398.00 
Total 98   
DASS Stress Score Insomnia 50 55.37 2768.50 
NREM Parasomnia 48 43.39 2082.50 
Total 98   
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Test Statistics
a
 
 
DASS 
Depression 
Score 
DASS Anxiety 
Score 
DASS Stress 
Score 
Mann-Whitney U 1044.000 1178.000 906.500 
Wilcoxon W 2220.000 2453.000 2082.500 
Z -1.117 -.158 -2.095 
Asymp. Sig. (2-tailed) .264 .874 .036 
a. Grouping Variable: 1=Good Sleeper; 2=Insomnia; 3=NREM Parasomnia 
 
 
 
Multiple Comparisons 
Bonferroni 
Dependent Variable 
(I) 1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia 
(J) 1=Good 
Sleeper; 
2=Insomnia; 
3=NREM 
Parasomnia 
Mean 
Difference 
(I-J) 
Std. 
Error Sig. 
98.75% 
Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
PSWQtransformedlog Good Sleeper Insomnia -.24788* .0570
5 
.000 -.4140 -.0818 
NREM 
Parasomnia 
-.24070* .0576
4 
.000 -.4085 -.0729 
Insomnia Good 
Sleeper 
.24788* .0570
5 
.000 .0818 .4140 
NREM 
Parasomnia 
.00718 .0576
4 
1.000 -.1606 .1750 
NREM Parasomnia Good 
Sleeper 
.24070* .0576
4 
.000 .0729 .4085 
Insomnia -.00718 .0576
4 
1.000 -.1750 .1606 
Arousal Predisposition 
Score  
Good Sleeper Insomnia -3.760 1.503 .040 -8.14 .62 
NREM 
Parasomnia 
-5.590* 1.519 .001 -10.01 -1.17 
Insomnia Good 
Sleeper 
3.760 1.503 .040 -.62 8.14 
NREM 
Parasomnia 
-1.830 1.519 .691 -6.25 2.59 
NREM Parasomnia Good 
Sleeper 
5.590* 1.519 .001 1.17 10.01 
Insomnia 1.830 1.519 .691 -2.59 6.25 
Rehearsal  Good Sleeper Insomnia -1.440 .620 .065 -3.25 .37 
NREM 
Parasomnia 
-2.809* .627 .000 -4.63 -.98 
Outcome variables: parametric data 
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Insomnia Good 
Sleeper 
1.440 .620 .065 -.37 3.25 
NREM 
Parasomnia 
-1.369 .627 .092 -3.19 .46 
NREM Parasomnia Good 
Sleeper 
2.809* .627 .000 .98 4.63 
Insomnia 1.369 .627 .092 -.46 3.19 
Emotional Inhibition  Good Sleeper Insomnia -1.100* .362 .009 -2.16 -.04 
NREM 
Parasomnia 
-1.317* .366 .001 -2.38 -.25 
Insomnia Good 
Sleeper 
1.100* .362 .009 .04 2.16 
NREM 
Parasomnia 
-.217 .366 1.000 -1.28 .85 
NREM Parasomnia Good 
Sleeper 
1.317* .366 .001 .25 2.38 
Insomnia .217 .366 1.000 -.85 1.28 
 
 
Outcome variables: non-parametric post hoc pairwise comparisons (Mann-Whitney) 
 
Ranks 
 1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia N Mean Rank Sum of Ranks 
AAQII score  Good Sleeper 50 38.94 1947.00 
Insomnia 50 62.06 3103.00 
Total 100   
 
Test Statistics
a
 
 AAQII score  
Mann-Whitney U 672.000 
Wilcoxon W 1947.000 
Z -3.994 
Asymp. Sig. (2-tailed) .000 
a. Grouping Variable: 1=Good Sleeper; 
2=Insomnia; 3=NREM Parasomnia 
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Ranks 
 1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia N Mean Rank Sum of Ranks 
AAQII score  Good Sleeper 50 38.55 1927.50 
NREM Parasomnia 48 60.91 2923.50 
Total 98   
 
Test Statistics
a
 
 AAQII score  
Mann-Whitney U 652.500 
Wilcoxon W 1927.500 
Z -3.901 
Asymp. Sig. (2-tailed) .000 
a. Grouping Variable: 1=Good Sleeper; 
2=Insomnia; 3=NREM Parasomnia 
 
Ranks 
 1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia N Mean Rank Sum of Ranks 
AAQII score  Insomnia 50 49.73 2486.50 
NREM Parasomnia 48 49.26 2364.50 
Total 98   
 
 
Test Statistics
a
 
 AAQII score  
Mann-Whitney U 1188.500 
Wilcoxon W 2364.500 
Z -.082 
Asymp. Sig. (2-tailed) .935 
a. Grouping Variable: 1=Good Sleeper; 
2=Insomnia; 3=NREM Parasomnia 
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Ranks 
 1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia N Mean Rank Sum of Ranks 
Sleep Arousal Scale 
cognitive  
Good Sleeper 50 28.49 1424.50 
Insomnia 50 72.51 3625.50 
Total 100   
Sleep Arousal Scale 
somatic  
Good Sleeper 50 29.22 1461.00 
Insomnia 50 71.78 3589.00 
Total 100   
 
Test Statistics
a
 
 
Sleep Arousal 
Scale cognitive  
Sleep Arousal 
Scale somatic  
Mann-Whitney U 149.500 186.000 
Wilcoxon W 1424.500 1461.000 
Z -7.597 -7.520 
Asymp. Sig. (2-tailed) .000 .000 
a. Grouping Variable: 1=Good Sleeper; 2=Insomnia; 
3=NREM Parasomnia 
 
Ranks 
 1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia N Mean Rank Sum of Ranks 
Sleep Arousal Scale 
cognitive  
Good Sleeper 50 35.44 1772.00 
NREM Parasomnia 48 64.15 3079.00 
Total 98   
Sleep Arousal Scale 
somatic  
Good Sleeper 50 33.80 1690.00 
NREM Parasomnia 48 65.85 3161.00 
Total 98   
 
 
Test Statistics
a
 
 
Sleep Arousal 
Scale cognitive  
Sleep Arousal 
Scale somatic  
Mann-Whitney U 497.000 415.000 
Wilcoxon W 1772.000 1690.000 
Z -5.008 -5.818 
Asymp. Sig. (2-tailed) .000 .000 
a. Grouping Variable: 1=Good Sleeper; 2=Insomnia; 
3=NREM Parasomnia 
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Ranks 
 1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia N Mean Rank Sum of Ranks 
Sleep Arousal Scale 
cognitive  
Insomnia 50 63.17 3158.50 
NREM Parasomnia 48 35.26 1692.50 
Total 98   
Sleep Arousal Scale 
somatic  
Insomnia 50 53.88 2694.00 
NREM Parasomnia 48 44.94 2157.00 
Total 98   
 
Test Statistics
a
 
 
Sleep Arousal 
Scale cognitive  
Sleep Arousal 
Scale somatic  
Mann-Whitney U 516.500 981.000 
Wilcoxon W 1692.500 2157.000 
Z -4.864 -1.565 
Asymp. Sig. (2-tailed) .000 .118 
a. Grouping Variable: 1=Good Sleeper; 2=Insomnia; 
3=NREM Parasomnia 
 
 
ECQ-EI, ECQ-R, PSWQ and APS between group ANCOVA using age as a 
covariate  
 
Tests of Between-Subjects Effects 
Dependent Variable:Emotional Inhibition (ECQ-EI) 
Source Type III Sum of 
Squares Df Mean Square F Sig. 
Corrected Model 50.353
a
 3 16.784 5.087 .002 
Intercept 370.784 1 370.784 112.376 .000 
Age 1.040 1 1.040 .315 .575 
 Group  48.733 2 24.366 7.385 .001 
Error 475.127 144 3.299   
Total 4839.000 148    
Corrected Total 525.480 147    
a. R Squared = .096 (Adjusted R Squared = .077) 
 
Dependent Variable:Emotional Inhibition (ECQ-EI) 
Group 
Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
dimension
1 
Good Sleeper 4.616
a
 .258 4.105 5.127 
   Insomnia 5.642
a
 .277 5.095 6.189 
NREM Parasomnia 5.960
a
 .273 5.420 6.501 
a. Covariates appearing in the model are evaluated at the following values: Age 
(years) = 38.91. 
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Tests of Between-Subjects Effects 
Dependent Variable:Rumination (ECQ_R) 
Source Type III Sum of 
Squares Df Mean Square F Sig. 
Corrected Model 193.919
a
 3 64.640 6.677 .000 
Intercept 447.313 1 447.313 46.202 .000 
Age .523 1 .523 .054 .816 
Group  193.169 2 96.585 9.976 .000 
Error 1394.156 144 9.682   
Total 6597.000 148    
Corrected Total 1588.074 147    
a. R Squared = .122 (Adjusted R Squared = .104) 
 
Dependent Variable:Rumination (ECQ-R)  
Group 
Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
dimension
1 
Good Sleeper 4.431
a
 .443 3.556 5.306 
Insomnia 5.819
a
 .474 4.882 6.756 
NREM Parasomnia 7.260
a
 .468 6.334 8.186 
a. Covariates appearing in the model are evaluated at the following values: Age 
(years) = 38.91. 
 
 
Tests of Between-Subjects Effects 
Dependent Variable: Worry (PSWQ datatransformed)  
Source Type III Sum of 
Squares Df Mean Square F Sig. 
Corrected Model 1.978
a
 3 .659 8.050 .000 
Intercept 196.291 1 196.291 2396.132 .000 
Age .000 1 .000 .001 .970 
Group 1.941 2 .970 11.845 .000 
Error 11.796 144 .082   
Total 2090.641 148    
Corrected Total 13.775 147    
a. R Squared = .144 (Adjusted R Squared = .126) 
 
 
 
Dependent Variable:PSWQtransformedlog 
Group 
Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
dimension
1 
Good Sleeper 3.584
a
 .041 3.504 3.665 
Insomnia 3.832
a
 .044 3.745 3.918 
NREM Parasomnia 3.825
a
 .043 3.740 3.911 
a. Covariates appearing in the model are evaluated at the following values: Age 
(years) = 38.91. 
 
Tests of Between-Subjects Effects 
Dependent Variable:Arousal Predisposition Score  
Source Type III Sum of 
Squares Df Mean Square F Sig. 
Corrected Model 981.731
a
 3 327.244 5.884 .001 
Intercept 17353.360 1 17353.360 312.028 .000 
Age 181.888 1 181.888 3.271 .073 
Group 818.895 2 409.447 7.362 .001 
Error 8008.512 144 55.615   
Total 158120.000 148    
Corrected Total 8990.243 147    
a. R Squared = .109 (Adjusted R Squared = .091) 
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Dependent Variable:Arousal Predisposition Score  
Group 
Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
dimension
1 
Good Sleeper 28.450
a
 1.061 26.353 30.548 
Insomnia 33.184
a
 1.136 30.938 35.429 
NREM Parasomnia 33.673
a
 1.123 31.453 35.892 
a. Covariates appearing in the model are evaluated at the following values: Age 
(years) = 38.91. 
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APPENDIX 2.10 
  Ethics approval letter 
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APPENDIX 2.11 
Participants removed from Good Sleeper group due to unequal sample sizes  
Participant  Gender  Age  
1* Male  64 
2* Female  26 
3* Male  42 
4 Female  36 
5* Male  27 
6 Male  41 
7* Female  40 
8* Female  43 
9* Male  23 
10* Female  32 
11 Male  25 
12 Female  38 
*= PSQI>5 
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APPENDIX 2.12 
Socioeconomic status data for participants living in Scotland 
 
Socioeconomic 
status 
GS (N=50) nREMp (N=30) Insomnia 
(N=41) 
X
2
 (2) P 
  N(%) N(%) N(%) N(%) 
SIMD quintile
a
      
1 8 7 7 4.85 0.09 
2 3 5 12   
3 8 7 3   
4 12 6 6   
5 19 5 13   
            
       
a
SMID quintile = Scottish Index of Multiple Deprivaton.  A quintile represents a 
statistical value of a data set that represents 20% of a given population.  The first 
quartile represents the lowest fifth of the data (1-20%) (i.e. most deprived); the second 
quartile represents the second fifth (21%-40%) etc.   
 
(www.scotland.gov.uk/Topics/Statistics/SIMD) 
  
GS = Good Sleepers, nREMp = nREM parasomnia 
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APPENDIX 2.13 
Frequency of participants within each DASS severity category 
 
    
DASS severity categories GS nREMp Insomnia 
(score range within 
category) 
N = 50 N=  50 N=  48 
  Frequency 
in category 
Frequency 
in category 
Frequency 
in category 
Depression     
Normal  (0-9) 49 35 31 
Mild (10-13) 1 3 4 
Moderate (14-20) 0 3 10 
Severe (21-27) 0 4 2 
Extremely severe (28+) 0 3 3 
     
Anxiety    
Normal (0-7) 50 24 31 
Mild (8-9) 0 9 8 
Moderate (10-14) 0 11 8 
Severe (15-19) 0 1 1 
Extremely Severe (20+) 0 3 2 
    
Stress     
Normal (0-14) 46 35 26 
Mild (15-18) 2 4 11 
Moderate (19-25) 2 4 6 
Severe (26-33) 0 3 7 
Extremely Severe (34+) 0 2 0 
    
GS = Good Sleepers, nREMp = nREM parasomnia 
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APPENDIX 2.14 
 Effect sizes for pair-wise comparisons of outcome measures 
Outcome Measure  Pairwise 
comparisons 
Effect size (d/r) P 
Emotional Inhibition    
ECQ-EI
a
 GS vs nREMp 0.69 0.001 
 GS vs I 0.63 0.009 
 I vs nREMp 0.12 1 
    
AAQ-II
b
 GS vs nREMp 0.39 0.000 
 GS vs  I 0.4 0.000 
 I vs nREMp 0.01 0.935 
    
Rumination & Worry    
ECQ-R
a
 GS vs nREMp 0.97 0.000 
 GS vs I 0.47 0.065 
 I vs nREMp 0.42 0.092 
    
PSWQ
a
 GS vs nREMp 0.92 0.000 
 GS vs I 0.89 0.000 
 I vs nREMp 0.07 1 
    
Arousability    
APS
a
 GS vs nREMp 0.79 0.001 
 GS vs I 0.5 0.040 
 I vs nREMp 0.23 0.691 
    
SAS cognitive
b
 GS vs nREMp 0.51 0.000 
 GS vs I 0.76 0.000 
 I vs nREMp 0.49 0.000 
    
SAS somatic
b
 GS vs nREMp 0.76 0.000 
 GS vs  I 0.58 0.000 
  I vs nREMp 0.16 0.118 
 
aEffect size = Cohen‟s d  
b 
Effect size =  r   
 
GS = Good Sleepers, nREMp = nREM parasomnia, I = Insomnia 
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APPENDIX 2.15 
Correlation matrix between the five outcome measures and DASS subscales 
 
 
  
ECQ-EI  AAQ-II   ECQ-R PSWQ APS 
SAS 
cognitive  
SAS 
somatic  
DASS 
Depression 
DASS 
Anxiety  
DASS 
Stress  
ECQ-EI                      
AAQ-II .303*                   
ECQ-R  .486* .346*                 
PSWQ .423* .475* .671*               
APS   .413* .530* .607* .668*             
SAS cognitive   .324* .395* .376* .487* .407*           
SAS somatic  .295* .493* .310* .435* .496* .601*         
DASS Depression  .366* .587* .308* .443* .462* .462* .555*       
DASS Anxiety  .457* .511* .337* .484* .544* .523* .694* .582*     
DASS Stress .414* .522* .482* .613* .540* .614* .579* .660* .669*   
 
*Correlation is significant at the 0.01 level (two-tailed)
 142 
APPENDIX 2.16  
 
General Structure of Parasomnia Treatment Programme 
 
Background 
 
Relatively little is known about the psychological profile of people with Non-REM 
Parasomnias, but it seems reasonable on the basis of what is known to presume that 
sleepwalking and night terrors are psychophysiological disorders.  Therefore they 
may be amenable to psychological interventions.  We are currently undertaking 
research at the University of Glasgow Sleep Centre exploring the psychological 
aspects of vulnerability and presentation of these patients.  We also have a regular 
clinic for people with Non-REM Parasomnias.  The Parasomnia Treatment 
Programme here, therefore, is based in good measure upon clinical intuition and 
experience.  Informal evaluation of this treatment programme by looking at outcomes 
and subjective value to patients will also give us a better understanding of the nature 
of Non-REM Parasomnias.   
 
The programme is structured as a 5 x 50 minute group session programme, in a style 
and format similar to the well established Glasgow CBT Programme for Insomnia.  
However the techniques are not by any means exclusively in the CBT tradition, but 
they are all influenced by psychological models of human behaviour, cognition and 
emotion. 
 
Session 1: Sleep Information and Education 
 
 Introduction to group and group members 
 What is sleep? 
 Sleep and human development 
 Common sleep disorders 
 Diagnostic features of Non-REM Parasomnia 
 How Non-REM Parasomnia differs from other forms of parasomnia 
 Relaxation training 
 Group discussion 
 Explanation of expectations of attending the group and of “boundaries” 
 Recognition that parasomnia is a common and shared problem whilst the 
opportunity for group discussion (within above boundaries) 
 Questions and answers (at the end, but also throughout) 
 
Session 2: Sleep-Wake Optimisation Therapy and Management of Risks 
 
 Establishing how much sleep you need 
 Sleeping at the right times 
 Managing napping and sleepiness 
 The use of ambient light and light-boxes 
 Avoiding sleep deprivation 
 Place of alcohol (and medications) 
 Creating a safe environment 
 Involving others to minimise risk 
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 Group discussion  
 Questions and answers  
 
Session 3: Personal Styles and Ways of Coping 
 
 Analysis of questionnaire data (worry, rumination, emotional expression, 
inhibition, etc.) 
 A mindful approach to who you are 
 Expressive writing tasks 
 Reflection, rehearsal and planning 
 Making sense of the parasomnia – a personal story 
 Group discussion  
 Questions and answers  
 
Session 4: De-conditioning and Behavioural Management 
 
 Predisposing, precipitating and perpetuating factors 
 Identifying internal and external triggers 
 Identifying stereo-type behaviour patterns 
 Introducing discriminative stimuli to aid self-awareness and/or to direct 
behaviour 
 Practicing extinction/de-conditioning 
 Involving a partner/carer in the treatment programme 
 Group discussion  
 Questions and answers  
 
Session 5: Additional Cognitive Strategies 
 
 Cognitive restructuring 
 Imagery training 
 Acceptance and commitment 
 Integration of the whole programme 
 Relapse prevention 
 Group discussion  
 Questions and answers  
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APPENDIX 2.17 
 
Major Research Project proposal 
 
Rumination, worry, emotional inhibition & arousability in adults with NREM 
parasomnias, insomnia & good sleepers 
 
Abstract  
  
Background  
Little is known about the psychological profiles of adults presenting with NREM 
parasomnias.  Research indicates that a common factor associated with the onset of 
NREM parasomnias is stress and there has been some investigation into the presence 
of mood disorders such as anxiety in people with NREM parasomnias, indicating a 
higher prevalence compared to healthy subjects.  There have been some suggestions 
that adults experiencing NREM parasomnias may be emotionally inhibited, however 
no research has directly investigated this.  When considering research into sleep 
disorders, one turns to the topic of insomnia and finds a greater understanding of its 
associated psychological factors.  Several studies have found a relationship between 
both worry and rumination and sleep quality.  Research has also emphasised the role 
of somatic and especially cognitive arousal in insomnia.   
 
Aims 
The study proposed is an investigation into these psychological factors in adults who 
experience NREM parasomnias.   
 
Methods  
A cross-sectional study with a primary index NREM parasomnia group, a parallel 
sleep disorder group of adults with insomnia and a control group of good sleepers.  
The three groups will be compared for differences on self-report measures of 
emotional inhibition, worry, rumination and arousal.      
 
Applications  
Gaining a deeper understanding of some of the psychological processes in adults 
experiencing NREM parasomnias could prove useful for clinicians when providing 
assessment and intervention with people presenting with these phenomena.   
 
Introduction 
What are NREM parasomnias?  
The group of sleep disorders collectively known as parasomnias are characterised as 
“undesirable physical or behavioural phenomena occurring during the sleep period” 
(Wills & Garcia 2002).  Common parasomnias include REM (Rapid Eye Movement) 
sleep behaviour disorder, nocturnal seizures, rhythmic movement disorders, bruxism 
and Non REM (NREM) sleep-arousal disorder (Wills et al 2002).  The study proposal 
described below will focus on NREM sleep-arousal disorders, also referred to as 
“NREM parasomnias”.  Overall characteristics of NREM parasomnias are that they 
tend to arise from stages 3 and 4 of NREM sleep (slow wave sleep) and in the first 
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third of the sleep cycle (Mahawold & Bourneman 2005).  The episode generally 
occurs in the first half of the night and the individual has near-total or total amnesia 
following the event (Vaughn & O‟Neil 2007).  This category of parasomnias includes 
night terrors, sleepwalking and confusional arousals (Mahawold et al 2005).  
Confusional arousals present as periods of mental confusion occurring upon arousal 
or awakening from sleep (Ohayon, Guilleminault & Priest 1999).  Night or “sleep” 
terrors are episodes of extreme terror associated with intense vocalisation and body 
motility and high levels of autonomic discharge (Kales, Cadieux, Soldatos & Kales 
1982).  The individual is completely fixated on this frightening experience and, whilst 
awareness is restricted as such, can not be reassured (Crisp 1996).  Sleepwalking or 
“somnambulism” is characterised by ambulatory activity during NREM sleep.  
Sleepwalking and night terrors have been reported in some cases to occur together 
(Ohayon et al 1999). 
 
These NREM parasomnias are described in the International Classification of 
Diseases (ICD-10) (World Health Organisation 1992) and the International 
Classification of Sleep Disorders (ICSD2) (American Academy of Sleep Medicine, 
2005).  In addition to the three main types described, more specific forms of NREM 
parasomnias have been reported including sleep-related eating disorder and sleep sex 
(Mahawold et al 2005).      
 
Prevalence of NREM parasomnias 
Incidents of confusional arousals, night terrors and sleepwalking are all more common 
in children than adults and usually decrease in frequency with increasing age 
(Mahawold et al 2005).  However their prevalence in adults has been found to be 
higher than is often assumed (Bornemann, Mahowald & Schenck, 2006).  In a study 
based on self-report data in a sample from the UK general population, Ohayon and 
colleagues found that night terrors were reported by 2.2% of the participants, 
sleepwalking by 2% and confusional arousals by 4.2% (Ohayon et al 1999).  In the 
same study no gender differences were found in any of the arousal disorders, however 
some studies have reported that sleepwalking is around twice as common in males 
compared to females (Crisp 1996). 
 
Why study NREM parasomnias?  
Most often people who experience NREM parasomnias live out their lives without 
coming to the attention of researchers or sleep professionals.  Professionals are only 
likely to become involved when harm is caused to the individual, the disorder 
becomes an inconvenience to others (such as the bed partner), it causes interruptions 
to sleep, or when secondary complications such as alcohol dependence arise (Crisp 
1996).  In severe cases incidents of homicide, filicide and suicide have been reported 
(Bornemann et al 2006).   Increasingly, experts in the field of these disorders are 
asked to give their opinion in legal cases where violent or injurious behaviours have 
purported to have arisen from sleep (Mahowold & Schenk 2005).   
Given the potential harmful, in some cases lethal, consequences of NREM 
parasomnias and the possible impact on an individual‟s quality of life, it is important 
to find out about the characteristics of those who experience them.  In particular it is 
important to delineate those factors that predispose, precipitate and perpetuate these 
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behaviours with the ultimate aim being to intervene where possible to reduce or 
eliminate their occurrence.  
 
What do we know about NREM parsomnias and when they occur?  
A common factor found to be associated with the onset of NREM parasomnias is 
stress (Pressman 2007).  In the study described above by Ohayon and colleagues 
higher rates of stressful life events and mental stress in the past year were reported in 
the group who experienced NREM parasomnias compared with those experiencing no 
such behaviour (Ohayon et al 1999).  Sleep deprivation and alcohol consumption have 
also been reported to be associated with NREM parasomnias (Pressman 2007).  
Investigating what factors were associated with the three main NREM parasomnias 
separately and controlling for possible effects of sleep deprivation, life stress and 
mental and sleep disorders, Ohayan found that factors associated with NREM 
parasomnias were shift work, daytime sleepiness and daily smoking.  A subjective 
sense of choking or blocked breathing at night, alcohol consumption at bedtime and 
nightmares at least one night per month were associated with night terrors.  
Sleepwalking was also associated with a subjective sense of choking or blocked 
breathing at night as well as being involved in a road accident in the past year.              
There has been some investigation into a possible relationship between 
psychopathology and NREM parasomnias.  Interestingly Kales and colleagues found 
more intense clinical manifestations and high levels of psychopathology in adult-onset 
sleepwalkers compared with adults who had been sleepwalkers in childhood (Kales, 
Soldatos, Caldwell, Kales, Humphrey & Charney 1980).  Ohayon found a high 
percentage of subjects with NREM parasomnias had concurrent mood or anxiety 
disorders, specifically mood disorders were found in 30.4% of those with night terrors 
and 14.6% with sleepwalking compared with only 5.7% in healthy subjects (Ohayon 
et al 1999).  
In a study investigating personality and psychoneurotic characteristics of adults with 
either sleepwalking or night terrors, Crisp and his colleagues found a normal 
psychological profile apart from exceptionally high scores on hysteria in both groups 
and high anxiety scores in the night terrors group (Crisp, Matthews, Oakey & 
Crutchfield, 1990).  Crisp notes that questions within the hysteria scale most often 
responded to positively were those to do with enjoying acting, dramatic situations, 
being the centre of attention and in the case of night terrors, being excessively 
emotional, but that few of these patients displayed such behaviour in wakefulness 
(Crisp 1996).  In reviewing literature on night terrors, Carlson et al (Carlson, White & 
Turkat, 1982) similarly points to a tendency of people with night terrors to “react with 
fear and apprehension and inhibit outward expression”.  Concurrent with this is the 
finding that sleepwalking and night terrors are more common in good, compliant 
children who do not show their emotions (Klackenberg 1982).  Despite these findings 
there has been no research directly investigating emotional expression or coping 
styles in adults presenting with arousal disorders.  
 
Turning to Insomnia 
When considering research into sleep disorders, one can turn to the topic of insomnia 
and find a greater understanding of its associated factors.  Increasing age, female sex 
and psychiatric, in particular anxiety and depression, and medical disorders are all 
consistently found to be risk factors for insomnia (Edinger & Means, 2005).  As has 
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been found with NREM parasomnias, various studies have shown that negative or 
stressful life events are often associated with insomnia (Morin, Rodrigez & Ivers 
2003).  In light of this some studies have investigated the role of appraisal of stressful 
events and coping in mediating between stress and insomnia.  Morin and colleagues 
reported that the frequency of daily minor stresses was comparable for good and poor 
sleepers but the perceived impact of those stressors was higher for insomniacs.  It was 
suggested that it is the appraisal process rather than the stress itself that is implicated 
in the presentation of insomnia. Vela-Bueno found that poor sleep quality was 
associated with rumination and emotional inhibition and that emotional inhibition acts 
as a mediating factor between rumination and sleep quality (Vela-Bueno, Fernandez-
Mendoza, Vgontzas, Ramos-Paton, Bixler, Olaverrieta-Bernardino & Dela Cruz-
Troca, 2008).  In another study investigating links between rumination and sleep, 
Thomsen and colleagues found a significant association between rumination and 
subjective sleep quality even after controlling for negative mood (Thomsen, Mehlsen, 
Christensen & Zachariae, 2003).  An experimental study inducing rumination about a 
negative event in the pre-sleep period established a causal link whereby high-trait 
ruminators allocated to a rumination condition reported poorer sleep quality than 
those assigned to a distraction condition.  Low-trait ruminators did not differ 
according to condition (Guastella & Moulds 2003).  Research has also shown a link 
between insomnia and the concept of “worry” which tends to be associated with 
anxiety (Harvey & Greenall, 2003).  Further research highlights the role of cognitive 
hyperarousal or arousability as a causal factor for insomnia (Coren, 1988).  There 
have been a number of research studies demonstrating a link between physiological 
arousal and insomnia (Monroe, 1967, Bonnet & Arand, 1995).  However, Lichtsein 
and Rosenthal showed that insomniacs experienced their sleeping difficulties to be 
caused more by cognitive arousal than by somatic arousal (Lichtsein & Rosenthal, 
1980).  Nicasso and colleagues later developed the Pre-Sleep Arousal Scale 
encompassing both cognitive and somatic manifestations of arousal (Nicasso, 
Mendlowitz, Fussell & Petras, 1985).  They found that whilst both cognitive and 
somatic arousal was related to insomnia, cognitive arousal showed a stronger 
relationship 
 
Aims and hypotheses 
 
Aims 
In light of what has been found out thus far with regards to people who experience 
NREM parasomnias, the proposed study aims to profile these phenomena in relation 
to a number of the psychological variables introduced above, namely emotional 
inhibition, worry, rumination and arousal.  A further objective would be to uncover 
any specificity of these variables to NREM parasomnias relative to another sleep 
disorder.   A cross-sectional study is therefore proposed with an index group of 
interest being the NREM parasomnia group, a parallel sleep disorder group of people 
with insomnia and a control group of good sleepers. 
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 Hypotheses 
The study aims to test the following hypotheses:  
 It is first hypothesised that, confirming findings from previous research, 
people with insomnia will have levels of a) Emotional inhibition, b)Worry,  
c)Rumination and d) Arousal that are elevated relative to good sleepers. 
 It is hypothesised that, relative to good sleepers, the group experiencing 
NREM parasomnia, also a psychophysiological disorder, will also have higher 
levels of: a) Emotional inhibition, b) Worry, c) Rumination and d) Arousal. 
Research questions 
It is not clear, however, whether there will be any differences on these variables 
between the NREM parasomnia and insomnia group and in what direction this may 
be.  There are therefore several research questions with regards to these two clinical 
groups:    
 Are there differences between the insomnia and NREM parasomnia group in 
the nature or degree of a) Emotional inhibition, b) Worry, c) Rumination and 
d) Arousal? 
 
Plan of Investigation 
Participants 
Participants allocated to the NREM parasomnia group and Insomnia will be selected 
based on criteria outlined in the (ICSD2) (American Academy of Sleep Medicine, 
2005) for NREM parasomnia and insomnia respectively.  Criteria for admission to the 
control group will include not meeting criteria for insomnia or NREM parasomnias 
and reporting satisfaction with the amount of sleep obtained, meeting research design 
criteria for good sleep.   
Inclusion Criteria  
 Participants to be included in the NREM parasomnia group must meet criteria 
for experiencing NREM parasomnias based on criteria outlined in the ICSD2  
 Participants to be included in the Insomnia group must meet criteria for 
primary Insomnia based on criteria outlined in the ICSD2  
 Participants to be included in the control group will include not meeting 
criteria for insomnia of NREM parasomnias and reporting satisfaction with the 
amount of sleep obtained.   
 For inclusion into each group, participants must be over 18 years of age and 
report English as their first language. 
Exclusion Criteria 
 Exclusion criteria for all groups would be (a) Symptomatic evidence of 
another sleep disorder (e.g. sleep apnoea or periodic limb movement disorder); 
(b) Sleep disturbance attributed to a psychiatric/medical condition or 
neurological disorder; (c) significant drug or alcohol use.  
  People meeting criteria for both a NREM parasomnia and insomnia will be 
excluded from the study.    
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Recruitment Procedures 
Participants will be recruited from the general population through the media, 
advertisements and clinical referrals in a manner consistent with the UGSC 
experience and operational procedures.   Advertisements may be placed, for example, 
in publications e.g. newspapers or the UGSC newsletter, in public spaces e.g. in 
hospitals, and on the internet e.g. on the UGSC website.  Participants may also be 
identified via an existing database held at the UGSC which has details of participants 
who have not been suitable for previous research and have agreed to be contacted for 
future studies.  Additionally, some potential participants may be identified through the 
parasomnia clinic which is ongoing at the UGSC.  This study is planned to be part of 
a larger programme of research and recruitment may come directly as well as via a 
parallel study (Sarah Young).  Suitable participants recruited into the parallel study 
will be offered the opportunity to take part in this study and vice versa.   
It is expected that people interested in participating in the study will contact the 
UGSC to declare an interest.  Potential participants would be screened via telephone 
using a standard screening interview administered to all participants intending to be 
involved in research at the UGSC in addition to screening interviews for insomnia and 
NREM parasomnias and specific health and demographic questions. This would be 
administered by staff members at the UGSC who are not involved in conducting the 
proposed study.  If deemed suitable, they will be sent an information sheet on this and 
the parallel study and a consent form through which participants can consent to this 
study and indicate if they would like to be contacted regarding the parallel study.  
Approximately one week after being sent this information, they will receive a phone 
call asking them if they wish to participate.    If they agree at this stage to participate 
in the study, they will be asked if they would like to participate via email, 
telephone/face-to-face interview or to receive the set of questionnaires by post. 
 
Design  
A between-groups cross-sectional study is proposed. 
 
Research Procedures 
It is expected that people interested in participating in the study will contact the 
UGSC to declare an interest by telephone or by email.  Potential participants would be 
screened via telephone interview which will include the following:  
 
Standard screening interview which is administered to all potential research 
participants at UGSC, with additional questions relating to health and 
sociodemographic factors and International Classification of Sleep Disorders II 
(ISCD-II) diagnostic criteria for insomnia and NREM parasomnias. 
 
Pittsburg Sleep Quality Index (PSQI)(Buyesse, Reynolds III, Monk, Berman & 
Kupter, 1989):  A self-report questionnaire which measures estimated sleep quality 
and disturbance over 1 month.  This will provide a quantitative measure of sleep 
disturbance as an addition to the above interview.  A global PSQI score of >5 has a 
reported sensitivity of 89.6% and specificity of 86.5% in distinguishing those with 
clinically significant sleep disturbance from those without.  The PSQI has been shown 
to have a satisfactory level of internal consistency (α = 0.83).  
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Depression Anxiety Stress Scales(21 items) (DASS21) (Henry & Crawford, 2004):  A 
21-item self-report measure of depression, anxiety and stress.  The DASS21 has been 
selected because it includes a specific stress scale and a large amount of data has been 
accumulated on this measure at the UGSC.  Internal consistency for the scales are 
satisfactory with α=0.93 for the total scale, and α=0.88 and α=0.82 and α=0.90 for the 
depression, anxiety and stress scales respectively.   
 
Sleep Conditioner Indicator (SCI) (Espie 2009): An unpublished measure which has 
been developed at the UGSC and for which data has thus far been collected on nearly 
2000 people.  The SCI is a self-report questionnaire in which participants are asked to 
report on the pattern of their sleep over the past month in addition to the quality of 
their sleep, the impact any poor sleep has had on their life and the level of concern 
they have had about their sleep.  Participants are also asked about the history of sleep 
problems.           
 
If deemed suitable according to the inclusion/exclusion criteria defined, they will be 
sent information sheets on this and a parallel study along with two separate consent 
forms. 
 
Approximately one week after being sent this information, they will receive a phone 
call asking them if they have considered participating in either of the research projects.      
 
If they agree at this stage to participate in this particular study, they will be asked if 
they would like to participate via email, telephone/face-to-face interview or to receive 
the set of questionnaires by post.  Depending on the preference indicated, an 
appointment will be arranged with participants for a telephone or face-to-face 
interview, they will be emailed a link to a website designed using survey monkey 
where they will be able to complete the questions online or they will be sent the 
questionnaires by post.  The questionnaires described below will be completed by 
each participant.  
 
Questions on Emotional Inhibition 
Emotion Inhibition Subscale of the Emotion Control Questionnaire (ECQ-R) (Roger 
& Najarian, 1989).  Participants are asked to rate 14 statements and situations as 
generally “true” or “false”.  E.g. “people find it difficult to tell if I‟m excited about 
something or not”.  The Emotion Inhibition Subscale has been shown to have good 
internal consistency (α=0.77) and test retest reliability (r=0.71) (Roger et al 1989).    
 
Acceptance & Action Questionnaire – II (AAQ-II) (Hayes et al 2009):  A 9-item 
questionnaire that measures experiential avoidance.  Questionnaire has good 
psychometric properties.* 
 
Questions on Rumination 
The Rehearsal Subscale of the ECQ-R.   Participants are asked to rate 14 statements 
and situations as generally “true” or “false”. Eg “I get worked up just thinking about 
things that have upset me in the past” “I remember things that upset me or make me 
angry for a long time afterward”.  The Rehearsal Subscale has been shown to have 
high internal consistency (α=0.86) and test re-test reliability (r=0.80) (Roger et al 
1989).  
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Questions on Worry 
Penn State Worry Questionnaire (PSWQ) (Meyer, Miller, Metzger & Borkovec, 
2004):  A 16 item self-report instrument which measures the trait of worry.  The 
PSWQ has strong internal consistency (α=0.95) and test re-test reliability (r=0.93). 
 
Questions on Arousability 
Arousal Predisposition Scale (APS) (Coren & Mah,1988): A 12-item self-report 
measure of arousability. The APS has a split-half reliability of 0.83 and has been 
shown to predict individual differences in physiological arousal (Coren et al 1988). 
 
The Sleep Arousal Scale (Nicasso, Mendlowitz, Fussell & Petras,1985):  A 16-item 
self-report measure which comprises both cognitive and somatic manifestations of 
arousal.  Internal consistency for somatic (8 items) and cognitive (8 items) are good 
(α=0.81 and α=0.76 respectively).      
 
It is anticipated that it should take approximately 20 minutes for a participant to 
complete this set of questionnaires.  For participants who have opted for the face-to-
face or telephone interviews, these will take place at the UGSC between 9am and 4pm 
on working week days.  Participants completing the online and postal questionnaires 
will be asked to complete these by a specified date allowing time for data analysis and 
write-up.  All participants will be asked to return a signed consent form.  
 
Justification of sample size  
No previous studies investigating any of the variables of arousal, emotional inhibition, 
worry and rumination in relation to a NREM parasomnia population have been 
identified on which to base an estimated effect size. However studies investigating 
insomnia groups compared to controls have yielded large effect sizes.  For example, 
using data from a study by Harvey & Greenall, 2003, an effect size of d=1.07 was 
found between an insomnia group compared to good sleepers on measures of worry, 
which would correspond to a large effect size according to Cohen‟s (1988) effect size 
conventions.   In answering its final research question, the proposed study is 
investigating possible differences between two clinical populations and it is likely that 
sufficient power will be required to detect a more conservative, medium effect size.   
A priori sample size calculations were conducted using the G*Power 3 software 
program (Faul, Erdfelder, Lang & Buchner, 2007) for an independent samples t-test 
(two-tailed).  With a significance level set at 0.05, a standard power of 0.8 and a 
medium effect size of d=0.5, it was calculated that a sample size of 64 would be 
required in each group.  I would aim to recruit up to 100 participants per group.  It is 
expected that obtaining this sample size would be sufficient to detect any significant 
differences between the two clinical groups, in addition to differences between the 
clinical and control groups.   
 
Settings and Equipment   
All research procedures will take place at the UGSC.  Equipment required will be a 
computer, printer, paper and envelopes (including freepost) and a telephone.   
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Data Analysis 
Data will first be summarised to provide descriptive statistics.  Before conducting 
formal analysis, all variables will be checked for normal distribution.  The intention 
would be to use a parametric approach and therefore use ANOVA models.  If the data 
are not normally distributed, the data will be transferred to normative data or non-
parametric tests would be used.  Group comparisons will be made using ANOVA to 
check that the three groups do not differ with respect to age, gender and 
socioeconomic status.  To investigate group differences with regard to the dependent 
variables (Emotional inhibition, worry, rumination and arousal), a series of ANOVA 
will be used.  If significant differences are found, a Bonferroni correction for multiple 
comparisons will be applied and the ANOVAs will be repeated.  Any variance of age, 
gender and socioeconomic status will be taken into account using ANCOVA.  
Relationships between the variables will be explored using correlations.   
  
 
Health and Safety Issues  
 
Researcher Safety Issues  
No researcher safety issues have been identified  
 
Participant Safety Issues 
If concerns are identified regarding a participants physical or mental health at any 
stage of the study, this will be reviewed by a clinical psychologist and an appropriate 
health professional will be contacted with the participants consent. Participants will 
also be given the opportunity to receive advice regarding their insomnia or NREM 
parasomnia  
 
Ethical Issues (including where submissions will be made) 
 
NHS ethical approval and R&D approval will be sought from the Greater Glasgow & 
Clyde and Ayrshire & Arran Health Boards.  Once this is passed, the study protocol 
will be shared with the Woolcock Institute in Sydney.  Should the Woolcock Institute 
be interested in recruiting for the study, they would have responsibility for gaining 
ethical approval via local procedures.  This is likely to be through the Royal Prince 
Alfred Hospital in Sydney.  Completion of the proposed study is dependent on 
recruitment from Glasgow and the United Kingdom alone and any recruitment from 
the Woolcock Institute will be supplementary to this.  
 
   
Financial Issues  
Equipment costs, travel etc  
     Financial aid for paper, printing and photocopying. Envelopes, stamps/freepost 
envelopes will be required to send out questionnaires and have them returned.  
Subscription to survey monkey.  A full costing summary will be submitted separately 
for approval.   
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Timetable  
 
Date MRP Progress/Tasks 
  
April 2010 
  
MRP Proposal submitted 
Costing form submission 
Completion of health and safety form 
  
May – September 2010 MRP research supervision agreement 
Start research logbook 
Ethics approval 
Research & Development approval 
Site preparation 
Ordering materials and administration supplies 
  
October 2010 Research Progress Meeting 1 
  
October – December 2010 Start data collection 
  
January – March 2011 Complete data collection 
Research Progress Meeting 2 
  
April – May 2011 Complete data analyses 
Research Progress Meeting 3 
  
June – July 2011 Submit drafts to supervisor 
  
July 2011 Loose bind and submit 
  
August 2011 Viva preparation 
  
September 2011 Viva 
  
September – November 2011 Submit corrections (if required) 
  
 
Practical Applications  
 
It is hoped that the outcome of this study would inform the assessment and treatment 
of clinically presenting cases with NREM parasomnias. 
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*Minor change to major research project: Used revised 7-item version of Acceptance 
and Action Questionnaire – II (AAQ-II), with improved psychometric properties 
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